Partners

 THANK YOU TO OUR ISCT 2025 CORPORATE PARTNERS

DIAMOND sponsors

MaxCyte® is a leading cell-engineering company driving the discovery, development, and commercialization of next-generation cell therapies. Our best-in-class Flow Electroporation® technology and SeQure Dx™ gene editing risk assessment services enable precise, efficient, and scalable cell engineering. Supported by expert scientific, technical, and regulatory guidance, MaxCyte’s platform empowers researchers to engineer diverse cell types and payloads, accelerating the development of safe, effective treatments. For over 25 years, we’ve been advancing cell engineering, shaping the future of medicine. Let’s Build Better Cells Together.™ Learn more at www.maxcyte.com.

Come meet us at Booth 736!


Visit Website

Miltenyi Biotec is a global provider of products and services that empower biomedical discovery and advance cellular therapy.

Our innovative tools support research at every level, from basic research to translational research to clinical application. This integrated portfolio enables scientists and clinicians to obtain, analyze, and utilize the cell. Our technologies offer solutions for cellular research, cell therapy, and cell manufacturing.

Our more than 30 years of expertise spans research areas including immunology, stem cell biology, neuroscience, cancer, hematology, and graft engineering. In our commitment to the scientific community, we also offer comprehensive scientific support, consultation, and expert training.

Today, Miltenyi Biotec has more than 4,000 employees in 28 countries – all dedicated to helping researchers and clinicians around the world make a greater impact on science and health.

Come meet us at Booth 507!

Visit Website

ScaleReady provides the field of cell and gene-modified cell therapy (CGT) with a G-Rex centric manufacturing platform that enables the world's most practical, flexible, scalable, and affordable CGT drug product development and manufacturing.

The G-Rex manufacturing platform is currently used by a rapidly growing list of over 800 organizations and is producing drug products for approximately 50% of CGT clinical trials as well as 5 commercially approved CGT drugs.

CGT entities relying on the breadth and scope of ScaleReady's expertise can expect to save years of time and millions of dollars on the path to CGT commercialization.

For more information about the ScaleReady G-Rex® Grant Program, please contact info@scaleready.com.

Come meet us at Booth 831!

Visit Website

Thermo Fisher Scientific provides the quality products, services, and support you need to translate your gene and cell therapy from drug discovery through large-scale commercial production. We’re working alongside the scientific community to accelerate the pace of gene and cell therapy development and enabling scientists like you to transform our approach to health care.

Come meet us at Booth 519!



Visit Website

Platinum sponsors

Cytiva is a global life sciences leader dedicated to helping customers discover and commercialize the next generation of therapeutics. Together, we bring dedicated technical expertise and a broad portfolio of tools and technologies that enable the development, manufacture, and delivery of transformative medicines to patients. Visit cytiva.com to learn more.


Come meet us at Booth 631!


Visit Website

Made Scientific is a leading cell therapy contract development and manufacturing organization (CDMO) dedicated to advancing the field of cell therapy. Since 2019, the company has specialized in developing, manufacturing, and releasing autologous and allogeneic cell therapy products for early- to mid-stage clinical trials, and has evolved into an end-to-end clinical-to-commercial service provider. Operating from two U.S.-based manufacturing facilities, Made Scientific combines the flexibility and entrepreneurial spirit of a specialist CDMO with the global expertise and resources of GC Corporation of South Korea, a global leader in the pharmaceutical and biotechnology sectors.

Come meet us at Booth 333!


Visit Website

Ori is a London and New Jersey-based manufacturing technology company pioneering flexible process discovery with seamless translation and scalable commercialization of cell and gene therapies.

Ori has developed a proprietary, full- stack manufacturing platform that closes, automates and standardizes CGT manufacturing, allowing therapeutics developers to develop and bring their products to market at commercial scale.

The promise of the innovative Ori platform is to automate CGT manufacturing to increase throughput, improve quality and decrease costs by combining proprietary hardware, software, data and analytics.



Visit Website

PBS Biotech offers unique single-use bioreactors and contract process development services for the global cell therapy market. Our family of Vertical-Wheel bioreactors provides a gentle and scalable platform suitable for a variety of cell types. Leverage the expertise within our process development services team to help solve cell culture challenges and accelerate your path to commercialization. Contact us at sales@pbsbiotech.com.


Come meet us at Booth 727!


Visit Website

We at Sartorius support the biopharmaceutical and life science research industries to develop and manufacture medications from the first idea to production. We’re in this together. For better health for more people.
At Sartorius, we empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine.
At Sartorius, we empower scientists and engineers to simplify and accelerate progress in life science and bioprocessing, enabling the development of new and better therapies and more affordable medicine.

Come meet us at Booth 223!


Visit Website

Sony Biotechnology Inc. is dedicated to helping researchers working across different life science disciplines to achieve the best scientific results.

By leveraging Sony's vast know-how in electronics innovation and design we offer next-generation cell analysis systems to accelerate your discoveries. 

Our goal is to bring a unique perspective to the flow cytometry tools required for in-depth single cell isolation and analysis.

With our core expertise in automation and software development we hope to enable discovery research across immunology, oncology, cell biology and microbiology.

Come meet us at Booth 813!


Visit Website

Terumo Blood and Cell Technologies is a medical technology company.

Our products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions.

Our employees around the world believe in the potential of blood and cells to do even more for patients than they do today. 

Come meet us at Booth 730!


Visit Website

As the advanced therapies business unit of WuXi AppTec, WuXi Advanced Therapies is a Contract Testing, Development and Manufacturing Organization (CTDMO) that offers advanced platforms and end-to-end solutions that enable the discovery, development, testing, manufacturing, and commercialization of cell and gene therapies. Our services and solutions accelerate time to market and support customer programs around the world.

For more information visit www.advancedtherapies.com.

Come meet us at Booth 720!


Visit Website

.

GOLD sponsors

BBG Advanced Therapies, a subsidiary of BioBridge Global, delivers a custom portfolio of solutions, including the collection and processing of starting materials, testing, and manufacturing services that bring lifesaving therapies to patients worldwide.


Come meet us at Booth 1014!


Visit Website

BD Biosciences is a leading provider of high-quality flow cytometry and single-cell genomics solutions, scientific research, and clinical laboratories. We are leading the way by developing technologies that allow for a closer look at the details of cells and diseases.


Visit Website

With more than 60 years of pioneering diagnostics, the people of bioMérieux understand the challenges you face when it comes to ensuring product quality and are proud to offer the most comprehensive portfolio of solutions for microbiology Quality Control of biopharmaceuticals and Cell & Gene Therapies.  Choosing the right microbiology diagnostic can boost efficiency with in-processes testing and automation simplifies the testing processes, reduces human error, and helps ensures data integrity. Rapid, simple, at-line testing of key parameters allows in-process tests to be performed closer to the production environment and provides certainty that your manufacturing process is secure.

Come meet us at Booth 615!


Visit Website

Catalent’s broad and industry-leading cell therapy expertise enables access to comprehensive solutions to get your life-saving cell therapies to the clinic faster and commercialize them more efficiently. With our advanced technologies and expertise in both autologous and allogeneic development and manufacturing, Catalent is your full-service CDMO partner for cell therapy.
Our unique and comprehensive cell therapy portfolio includes a wide range of expertise across a variety of cell types including chimeric antigen receptor T cells (CAR-T), T cell receptors (TCR), tumor-infiltrating leukocytes (TILs), natural killer cells (NKs), iPSCs, and MSCs. Catalent enables fully integrated cell therapy services, from iPSC differentiation, development, and manufacturing expertise, to process and analytical development across cell types, to clinical and commercial manufacturing in the United States and Europe. 

Come meet us at Booth 926!


Visit Website

Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle™ integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. While the Cell Shuttle™ automates cell therapy manufacturing, the Cell Q™ automates quality control at high throughput, both for in-process and batch release QC addressing both manufacturing and QC bottlenecks. Cell Shuttles and Cell Qs will be deployed in Cellares’ IDMO Smart Factories around the world enabling each Smart Factory to produce 10 times as many cell therapy batches as conventional CDMOs with the same facility size and number of employees. Partnering with Cellares enables academic medical centers, biotechnology companies, and pharmaceutical companies to accelerate cell therapy development, scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.

The company is headquartered in South San Francisco, California with its first commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. Cellares is building a global network of IDMO Smart Factories with additional facilities under construction in Europe and Japan. The company is backed by world-class investors and has raised over $355 million in financing.

For more information about Cellares, please visit cellares.com.

Come meet us at Booth 1024!


Visit Website

Corning offers solutions for efficiently scaling up cell cultures for cell therapy from research to production.

Open and closed systems solutions supporting adherent cell culture scale-up include CellSTACK® and HYPERStack® vessels, the CellCube® circulation-based system, the novel high-yield Ascent® FBR platform, and polystyrene and Corning Vanish® dissolvable microcarriers.

Corning cell culture surfaces enhance the binding and growth of specialized and fastidious cell types in low and non-serum media environments and offer functional, structural, and surface charge modalities.

Corning supports suspension workflows with Erlenmeyer flasks, disposable spinner flasks, bags, and closed system accessories.

Corning customers are supported by Corning Field Application Scientists and Scientific Support Specialists with extensive expertise in cell biology and process optimization for cell therapy research and production. 

Learn more at www.corning.com/lifesciences. 

Come meet us at Booth 912!


Visit Website

Mayo Clinic's biomanufacturing efforts are supported by a comprehensive set of capabilities, encompassing advanced process development laboratories and cGMP manufacturing facilities within the Center for Regenerative Biotherapeutics (CRB).

The Center emphasizes quality systems oversight, regulatory guidance, clinical trial support, and business development assessment. Mayo Clinic CRB has consolidated its process development operations into a state-of-the-art 16,000 sq ft facility at the Two Discovery Square building in Rochester, MN, which will focus on process development and quality control, offering extensive tissue culture, tissue engineering, analytical capabilities, and a ISO7 pilot plant for process testing. Biomanufacturing efforts cover cell-based therapies, biomaterials-based approaches, tissue engineering, bioprinting, gene and immunomodulatory therapies, and extracellular vesicle-based strategies.

Mayo Clinic's regional facilities include its primary site, One Discovery Square, in Rochester, MN; expanding process development, quality control and GMP manufacturing at the Florida campus within the Discovery and Innovation Center; and unique bioprinting and electrospinning capabilities, at the Arizona campus. Critical translational management at Mayo Clinic CRB involves defining critical process parameters, quality attributes, and assessing manufacturing feasibility to support automation and high-throughput platforms. Industry partnerships play a crucial role in accelerating commercialization, with Mayo Clinic leveraging CRB enterprise collaborations for device development and commercialization.

Managing over 2,500 active clinical trials, including more than 31 led by CRB, Mayo Clinic's manufacturing capabilities span cellular therapies, gene and viral therapy, tissue engineering, bioprinting, and exosomes. Overall, Mayo Clinic is well-positioned to support advanced biomanufacturing needs from early development through clinical and commercial stages. 

Come meet us at Booth 625!


Visit Website

STEMCELL Technologies supports scientific research globally with over 2,500 tools and services for regenerative medicine, cell therapy, immunotherapy, and disease research. Inspired by knowledge, innovation, and quality, we are Scientists Helping Scientists.


Come meet us at Booth 501!


Visit Website

Silver sponsors

Accellix was founded on the basis of creating a rapid, easy-to-use, automated cell phenotyping platform for point of need environments, focusing on cell therapy. Accellix is bringing next-generation analytical capabilities to its customers, enabling the measurement of critical quality attributes at every QC phenotyping interrogation point throughout the manufacturing process and the release of cell therapy products—when and where required.

Currently, these assays are performed on standard flow cytometers in centralized labs which require skilled technicians, high maintenance, a separate lab space, and a long turnaround time. There is a growing need for simpler more automated technologies that can fit seamlessly into centralized and de-centralized point-of-need models.

Accellix aims to bring the power of flow cytometry to the GMP manufacturing floor, automating the entire GMP cell phenotyping process from sample preparation to data analysis with the Accellix Platform. Accellix brings automated sample preparation, flow cytometry and data analysis directly into the manufacturing suite.

The Accellix team is an interdisciplinary group composed of skilled biologists, engineers, mathematicians, technicians and more with deep experience in all aspects of cell therapy in general and the immunotherapy field. Accellix has growing offices in Jerusalem, Israel and San Jose, CA.

Come meet us at Booth 603!


Visit Website

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in over 10 different cities within the United States, Switzerland, England and Germany. ACROBiosystems Group has established numerous long-term and stable partnerships with the world’s top pharmaceutical enterprises, including Pfizer, Novartis, and Johnson & Johnson, and numerous well-known academic institutes. The company comprises of several subsidiaries such as ACROBiosystems, bioSeedin, Condense Capital, and ACRODiagnostics.
ACROBiosystems’ brands include FLAG, Star Staining, ViruStop, Aneuro, ComboX, GENPower, and many others. Its main products and services are recombinant proteins, kits, antibodies, scientific services, and other related products. ACROBiosystems employs a strict quality control system for its products that are used in biopharmaceutical research and development, production, and clinical application. This includes targeted discovery and validation, candidate drug screening/optimization, CMC development and pilot production, preclinical research, clinical trials, commercial production, and clinical application of companion diagnostics.
Through the continuous development of new technologies and products, ACROBiosystems Group creates value for the global pharmaceutical industry and actively empowers our partners. The company is dedicated to accelerating the drug development process, including targeted therapies, immunotherapeutic drugs, and its clinical applications, and contributes to global health.
Come meet us at Booth 328!

Visit Website

Ajinomoto is globally recognized both for its pioneering work in the food industry and for its expertise in biotechnology and life sciences. In addition to our leadership in food innovation, we specialize in the development of regenerative medicine culture media and growth factors.

 Our products support cutting-edge research and clinical applications, maintaining the highest standards of safety and quality. Leveraging our strength in GMP and Animal-Origin-Free (AOF) production, we provide reliable solutions for cell therapy and regenerative medicine. Ajinomoto continues to drive innovation and foster partnerships, contributing to the future of healthcare.

Come meet us at Booth 804!


Visit Website

Akron Bio enables the advancement of cell and gene therapies through its portfolio of cytokines and media supplements, as well as its comprehensive suite of manufacturing services, including the production of plasmid DNA, precision gene editing tools, and specialized medias. Akron partners with advanced therapy developers, providing them with critical materials and services at the scale, level of compliance, and regulatory support necessary to drive novel treatments from discovery to commercialization, thereby addressing critical unmet needs in the patient community.


Come meet us at Booth 221!


Visit Website

BioLife Solutions is a leading developer, manufacturer and supplier of class-defining cell and gene therapy bioproduction tools and services. Our solutions facilitate basic and applied research and commercialization of new therapies by maintaining the health of biologic source material and finished products during manufacturing, storage and distribution.


Come meet us at Booth 819!


Visit Website

Bio-Techne is headquartered in Minneapolis, Minnesota and employs over 3,000 people
globally at 34 locations worldwide. As a global developer, manufacturer and supplier of high-
quality reagents, analytical instruments and precision diagnostics, Bio-Techne has an extensive
catalog of over 500,000 products.
Incorporated in 1981 as R&D Systems, the company changed its name to Bio-Techne in 2014. Our
growth has been accelerated through acquisitions, organic investments, diversification of our
customer base and expansion into new markets. In fiscal year 2023, Bio-Techne delivered net
sales of over $1.1 billion.
Bio-Techne includes the following brands: ACD, Asuragen, ExosomeDx, Lunaphore, Novus
Biologicals, ProteinSimple, R&D Systems and Tocris Bioscience.

Come meet us at Booth 932!


Visit Website

Cryoport, Inc. is a global leader in supply chain solutions for the Life Sciences with an emphasis on cell & gene therapies. Cryoport enables manufacturers, contract manufacturers (CDMO's), contract research organizations (CRO's), developers, and researchers to carry out their respective business with products and services that are designed to de-risk and provide certainty. We provide a broad array of supply chain solutions for the life sciences industry. Through our platform of critical products and solutions including advanced temperature-controlled packaging, informatics, specialized bio-logistics services, bio-storage, bio-services, and cryogenic systems, we are "Enabling the Future of Medicine™" worldwide, through our innovative systems, compliant procedures, and agile approach to superior supply chain management.


Come meet us at Booth 931!


Visit Website

FUJIFILM Irvine Scientific supports cell and gene therapy manufacturers with over 50 years of cell culture media knowledge and expertise. Our products advance the development of processes and workflows, to help users obtain optimal performance and safety of their final manufactured cells. We deliver high-performance media and expert support that can directly influence advanced cell and gene therapies. By providing innovative, first-to-market products and workflow solutions, we holistically drive and accelerate user efforts with complete media solutions for basic, translational, and clinical research, as well as commercial applications.

Come meet us at Booth 1018!


Visit Website

Hitachi is developing businesses related to diagnosis, treatment, and digital healthcare in Japan and overseas with the purpose of “Innovating Healthcare, Embracing the Future”.


In the regenerative medicine or cell and gene therapy field, our product and service offerings range from comprehensive engineering service for GMP facilities, automated cell culture equipment, digital engineering service and digital solutions (Manufacturing Execution System, value chain tracking system etc.). We provide complete cleanroom solutions for GMP facility, including design and construction, integration of cell processing equipment, maintenance, and validation.


Visit Website

Lonza is a preferred global partner to the pharmaceutical, biotech and nutrition markets. We work to enable a healthier world by supporting our customers to deliver new and innovative medicines that help treat a wide range of diseases. We achieve this by combining technological insight with world-class manufacturing, scientific expertise and process excellence. 

Our Cell & Gene offering spans across development and manufacturing services, products, solutions, testing and automation platforms as well as tools and technologies to enable you to develop, de-risk and industrialize your therapy, from basic research to commercialization.

Come meet us at Booth 714!

Visit Website

LumaCyte’s advanced real-time bioanalytics platform, Radiance®, is a label-free, single cell approach for quantitative characterization of innate cellular responses, without the need for antibody or genetic labeling.

This revolutionary technology utilizes Laser Force Cytology™ (LFC) to measure subtle phenotypic changes based purely on the intrinsic biophysical and biochemical properties of cells in response to their environment or treatment.

Come meet us at Booth 721!


Visit Website

As the world leader in serving science, Thermo Fisher Scientific is uniquely positioned to provide the quality materials, services and support needed to accelerate cell and gene therapy development.  


Visit Website

Repligen, a global life sciences company, develops and commercializes innovative bioprocessing technologies that increase efficiencies and flexibility in biotherapeutic manufacturing. As leaders in filtration, chromatography systems, process analytics and fluid management, we are committed to inspiring advances in bioprocessing. We are a trusted partner in the production of monoclonal antibodies, recombinant proteins, vaccines as well as cell and gene therapies.  Named one of the fastest growing biotech companies in the USA, the majority of our 18 manufacturing sites are located in the United States (California, Massachusetts, New Jersey, New Hampshire, New York and Texas). Outside the United States, we have manufacturing sites in Estonia, France, Germany, Ireland, the Netherlands, and Sweden.  


Come meet us at Booth 525!


Visit Website

SUPPORTERS

The Association for the Advancement of Blood & Biotherapies (AABB) is an international, not-for-profit organization representing individuals and institutions who are instrumental in making biotherapies safe, effective, and available worldwide.

The Association works collaboratively to advance the field through the development and delivery of the AABB standards, accreditation, and education programs. Additionally, we work with our membership to drive policies that advance novel biotherapies research and increase patient access to biotherapies.

Our Biotherapies offerings help companies increase their speed to market through the identification of well-qualified partners, increased competence through credentialing and education and increased visibility in the biotherapies community.

Come meet us at Booth 921!


Visit Website

Accesso Biotech Corporation is launching the Ecco™ Imaging Cytometer, designed for the cell therapy product development and manufacturing market. Built on the same technology as the VITA™ point-of-care CD4 counting system, developed for AIDS patients in low- and middle-income countries, the Ecco™ Imaging Cytometer enables flow cytometry-like immunophenotyping and absolute cell counting of gated cell populations-without the need for lasers, fluidics, or counting beads. This low-cost, portable, and easy-to-use system is ideal for routine testing in blood centers and QC testing in GMP environments. Its cartridge-based format allows for direct immunophenotyping and cell counting using whole blood samples—without the need for lysing or washing. We welcome inquiries for custom assay development as well as requests for demo testing. 
Come meet us at Kiosk #1 at the Innovation Zone!

Visit Website

A superior sequencing service, base by base.
ACGT is a Sanger DNA sequencing, NGS and molecular biology service provider committed to the aims of the life science research community. Our clientele consists of major research institutions, biotech firms and public health agencies. ACGT facilities are CLIA and CAP accredited and our services are offered as research grade, clinical or regulatory cGMP/GLP compliant.
Come meet us at Booth 924!

Visit Website

Valuing Life, Granting Advanced Therapies to Patients- that Is Adva Biotechnology’s Vision and goal. Adva biotechnology developed the ADVA X3® a simple, smart, easy to use, automated, sensors-based, flexible cell manufacturing platform.

Adva Biotechnology is a private company located in northern Israel. The Adva Biotechnology unique team is composed of biologists, biotechnologists, engineers that bring their expertise to create novel and innovative technologies for advanced cell therapies.

Knowing the need for smart adaptive automation, and understanding that processes change and varies, the ADVA biotechnology team developed the ADVA X3® - a simple, smart, easy to use, automated, sensors-based, flexible platform. The ADVA X3® enables full manufacturing process based on the CAMP® technology, of different applications, such as CAR-T, TCR, TIL, NK, Exosomes, Viruses and More.
Come meet us at Booth 941!

Visit Website

Aenitis develops innovative, cost-effective acoustic’s-based cell handling bioprocessing systems dedicated for cell sorting, cell washing, cell’s confinement and cell isolation.
Aenitis devices and module type package engineering services fits with needs of Cell and Gene Therapy Units, Biopharma, Biotechs, CDMOs and Research labs.
Aenitis promotes Mitis™, a device for high flow gentle cell handling, with technological approach that permits to handle cell in continue with no mechanical stress and in sterile condition which meet GMP compliance for bioprocessing requirement.
High flow acoustic cell handling appears as an alternative to the limits of legacy bioprocessing technologies.
We will be pleased to explore possibilities to organise first trials with you!
Visit our website for further information on www.aenitis.fr
Come meet us at Booth 637!


Visit Website

AmplifyBio is a partner-oriented CRO and CDMO founded on the principle that providers
must offer flexible approaches to product characterization, safety, and manufacturing to
de-risk timelines and reduce COGs for drug developers. AmplifyBio built a development
environment with integrated expertise and technology platforms across three sites dedicated
to characterization and optimization, safety and efficacy studies, and manufacturing suites
that work in concert to deliver customizable commercialization solutions to clients who need
reproducible, scalable, safe products that meet critical timelines.

Come meet us at Booth 533!


Visit Website

Accelerate your discovery with exceptional service and innovative, cutting-edge life science products
Founded over 35 years ago, AMSBIO is a premier life sciences supplier dedicated to meeting diverse research needs.


AMSBIO’s product lines are carefully curated with top tier products to give high choice and quality control, as well as offering advanced, flexible and tailored custom services. In addition, AMSBIO’s focus on generally underserved areas, such as Glycobiology, highlights a wider mission to advancing niche fields in life science.


AMSBIO is ISO9000 Certified to ensure easy partnerships, and with European, US, and UK distribution hubs, global shipping and no minimum order quantities, AMSBIO is committed to making products accessible to researchers worldwide.


AMSBIO’s Key Areas:
- Biorepository: AMSBIO’s one stop shop for tissues and biospecimens.
- Stem Cells: Source, grow, store, differentiate and manufacture stem cells using AMSBIO products from research through to clinical applications.
- 3D Cell Culture: Aiding in the creation of cultures that are relevant, robust and reproducible.
- Kits and Assays: Extensive range of ready-to-use and custom kits for drug discovery and biomedical research.
- Custom Services: Bespoke solutions to meet life science research requirements, especially around viral delivery, aptamers, antibodies, protein expression, CAR-T development, magnetic beads, cryopreservation media, and tissue procurement.
- Glycobiology: Specialized products and expertise in glycobiology research, vital for cellular biology and drug discovery.


For more information, visit AMSBIO’s website, talk to one of the product team on the online live chat function, talk via email on info@amsbio.com, or follow AMSBIO on LinkedIn.

Come meet us at Booth 915!


Visit Website

Anemocyte, a Biotech Manufacturing Organization based in Italy, offers development and manufacturing services and innovative solutions from R&D to GMP to address needs in the field of: - pDNA - Plasmids for Viral Vector and RNA manufacturing; - mRNA ' mRNA manufacturing for Vaccines and Therapies. Our experience: > 20 years of manufacturing innovative Therapies.

Come meet us at Booth 438!


Visit Website

Founded in 2008 to provide industry and academic researchers with the ability to leverage the power of induced pluripotent stem cells (iPSC) and gene editing, Applied StemCell continues to use our innovative technologies to power the discovery and development of advanced therapeutics. Our products and services enable the full spectrum of basic research to early-stage GMP manufacturing—including disease modeling, iPSC services, mammalian cell line engineering, and nonclinical and pre-IND studies—and our patented technologies ensure a clear IP path to commercialization.

Come meet us at Booth 329!


Visit Website

Aseptic Technologies manufactures fill & finish equipment and devices for advanced pharmaceutical manufacturing. Our core expertise lays in the innovation of aseptic filling processes for biopharmaceutical products, including cell and gene therapy products.
The AT-Closed Vial® Technology is an innovative vial, closed before filling, made out of polymer materials. Together with our Filling Lines, the technology allows for contamination risk reduction and higher levels of sterility. In addition, its exceptional features make the AT-Closed Vial® able to maintain Container Closure Integrity (CCI) at cryogenic temperatures (down to -196°C).
As a member of SKAN Group, we leverage the technological excellence of SKAN in the isolator design, providing integrated solutions for fill & finish projects, globally. Furthermore, we share decades of expertise in injection molding and manufacturing in cleanroom, offering customized ready-to-use assemblies for pharmaceutical processes.

Come meet us at Booth 839!

Visit Website

Asimov’s mission is to advance humanity’s ability to design living systems, enabling biotechnologies with outsized societal benefit. The company is developing a synthetic biology platform – from cells to software – to design and manufacture next-generation therapeutics, including biologics, cell/gene therapies, and RNA through a combination of products, services, and collaborations. 

Founded by bioengineers from MIT and Boston University and headquartered in Boston, the company has raised over $200 million from top institutional investors including Andreessen Horowitz, CPP Investments, Horizons Ventures, and Fidelity Management & Research Company. For more information, visit www.asimov.com.

Come meet us at Booth 621!

Visit Website

Astraveus aspires to radically reduce complexity and cost of cell therapy manufacturing. For that purpose, we are developing the LAKHESYS Benchtop Cell Therapy Factory, a microfluidic platform for fully automated, end-to-end cell therapy processing, scalable from process development to commercial manufacturing.
Due to the radical miniaturization of the LAKHESYS Benchtop Cell Therapy Factory, the manufacturing footprint, labor and use of expensive process materials required for cell therapy manufacturing can be reduced by a factor of ten.
The LAKHESYS Benchtop Cell Therapy Factory has been developed and tested to enable parallelized and automated cell therapy processing in an end-to-end fashion, i.e. from cellular starting material to the final drug product, thus covering all critical process steps.
The use of proprietary microfluidic technology enables highly efficient cell processing through rapid mass transfer under low shear stress. The parallel operation of microfluidic cell processing units allows for simultaneous manufacturing of up to ten cell therapy doses in only one system. The integrated image-based cytometry module enables on-board control of critical process parameters and quality attributes such as cell phenotype, transduction efficiency and cell viability.
Through this holistic approach, Astraveus minimizes process development effort and maximizes manufacturing output, thus enabling access to care for patients in need.


Visit Website

AventaCell BioMedical Corp. ("AventaCell") is among the world leaders devoted to developing novel human-derived products for use in cell culture and tissue regeneration.

Helios Bioscience is AventaCell's product family brand for their products to be used in cell culture and tissue regeneration. AventaCell technologies used in the Helios Bioscience line offer new human-derived solutions for use in translational research of cell and tissue-based therapies to meet the need for animal serum-free cell expansion and production.

The demand for safe, efficient and cost-effective cell expansion and production is rapidly increasing with the growth in cell therapy and regenerative medicine research and clinical development.

Helios Bioscience products are designed to support expansion and production of a broad range of cells including mesenchymal stem cells and multiple immunocell lines.

AventaCell is committed to providing animal serum-free products to accelerate the research, development and commercialization of safe and efficacious cell and tissue-based therapeutics.

Come meet us at Booth 706!


Visit Website

Brooks Life Sciences Services and Products business is rebranded under the creation of a new identity – Azenta Life Sciences. Azenta is dedicated to enabling life sciences organizations around the world to bring impactful breakthroughs and therapies to market – faster.

Azenta Life Sciences encapsulates our commitment to helping customers reach new heights in their pursuit of scientific progress. By integrating our industry-leading capabilities, Azenta Life Sciences enterprise-wide sample exploration and management solutions will accelerate discovery, development and delivery, with greater speed and precision.

At Azenta, we strive to keep elevating each other, our customers’ work and our industry – building a healthier world for people everywhere.

Come meet us at Booth 639!


Visit Website

Since 1986, Biocair has established a global reputation as a leading GDP logistics specialist within the pharmaceutical, biotechnology and life sciences sectors. Biocair has built up a unique, client-centric approach by employing scientists in front-line logistics positions and assembling a team of best-in-class industry experts in quality, cold chain and regulatory compliance. Biocair focuses on providing the most comprehensive time-sensitive and temperature-controlled logistics services available while delivering flexible, tailored, cost-effective solutions to all its clients. It is committed to delivering complete end-to-end logistics solutions through its global network spanning across Europe, Africa, Asia and the Americas.
Biocair employs 475 people worldwide and provides specialist logistics services to more than 160 countries through a global network of partners. Biocair’s offices are located in the United States, United Kingdom, France, Belgium, Germany, South Africa, China and India.
For further information on Biocair's cell therapy logistics solutions, please visit: biocair.com/solutions/cell-and-gene-supply-chain


Come meet us at Booth 235!


Visit Website

BioIVT enables smarter science and accelerates medical breakthroughs by delivering high-quality personalized biospecimen solutions and research services to life science and diagnostic industries. Recognized as an industry leader, BioIVT specializes in control and disease state samples including
human and animal tissues or preparations, ADME-Tox products and research services, cell and gene therapy products, blood, and other biofluids.
By combining technical expertise and exceptional customer service with unmatched access to biological specimens, BioIVT serves the research community as a trusted partner in
ELEVATING SCIENCE®.


Come meet us at Booth 121!


Visit Website

BioLamina is a biotechnology company with a scientific base and heritage in matrix biology and cell culture research. It supports scientists who have struggled for decades to grow pluripotent stem cells and other primary cells in the lab. By providing tools for efficient and easy cell culture, BioLamina aims to ease the path towards safe and effective cell therapies and make better cell assays and models for increasing accuracy in drug discovery and development. The power of Biolaminin® substrates, developed by BioLamina, has been demonstrated in numerous publications, and they will continue to provide vital support to the stem cell community—from scientific concepts to clinical studies. Based in Stockholm (Sweden), the company currently employs 90 people. The company’s main shareholders include Bure Equity AB (via Bure Growth), the Tryggvason family (the company’s founders), Northislet AB, and Lauxera Capital Partners.


Come meet us at Booth 607!


Visit Website

About Revvity and BioLegend (part of Revvity)
Revvity provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. We are revolutionizing what’s possible in healthcare, with specialized focus areas in translational multiomics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics, and more.

Come meet us at Booth 644!



Visit Website

With more than 60 years of pioneering diagnostics, the people of bioMérieux understand the challenges you face when it comes to ensuring product quality and are proud to offer the most comprehensive portfolio of solutions for microbiology Quality Control of biopharmaceuticals and Cell & Gene Therapies.  Choosing the right microbiology diagnostic can boost efficiency with in-processes testing and automation simplifies the testing processes, reduces human error, and helps ensures data integrity. Rapid, simple, at-line testing of key parameters allows in-process tests to be performed closer to the production environment and provides certainty that your manufacturing process is secure.

Come meet us at Booth 615!



Visit Website

For over 30 years, Bionique Testing Laboratories continues to be a trusted partner and global leader in Mycoplasma Testing Services for the life science industry.

We offer the full range of testing services from relevant compendia (USP <63> Mycoplasma Test) to a GMP compliant Real-Time PCR assay to support the development and clinical manufacturing of cell & gene therapies.

From discovery to commercialization, our capabilities extend to method development and validation of rapid microbial methods to meet global regulatory requirements. Bionique delivers testing services that meet the highest quality standards and offers the fastest turnaround times in the industry.

Come meet us at Booth 619!


Visit Website

Bio-ReCell is a cell therapy research and development company at the forefront of biomedical advancement.

Our team of seasoned experts in the field alongside young researchers, has led to the creation of the world's first closed and automated Bio-ReCell System, redefining cell separation and isolation standards within the industry.

Our revolutionary technology relies on a proprietary antibody-based approach, completely eliminating the need for magnetic particles. This innovation ensures that the resulting cell eluates are entirely devoid of contaminants, including residual antibodies, chemicals, and any other particles.

We maintain rigorous standards of sterility and bio compatibility, employing closed-loop cartridges tailored to specific cell types, which complete the isolation process in under 30 minutes. Scalability is a fundamental feature of our technology, accommodating the full spectrum of requirements, from single-patient applications to large-scale Good Manufacturing Practice (GMP) manufacturing processes.

Our versatile portfolio of cartridges targets various therapeutic objectives, primarily focusing on T-cells for advanced CAR-T therapies. Our product range includes also a system for cell activation, based on our proprietary technology. Bio-ReCell actively seeks strategic partnerships in both, commercial and research sectors, with a strong commitment to advancing cell and gene manufacturing and exploring novel clinical applications through collaborative clinical trials.

Come meet us at Booth 537!


Visit Website

The market’s most experienced provider of apheresis derived products, the BioSharing Network is a partnership between eight US blood centers.

The network has over two million donors and has decades of experience recruiting donors and performing apheresis procedures.

Our network provides GMP (mobilized & non-mobilized) leukopacks, bone marrow, cord blood and perinatal tissue, as well as providing support services including flowcytometry, cryopreservation and prodigy-based manufacturing.

With multiple donor rooms, clean rooms for manufacturing, and strong logistics teams, we are a the most reliable provider in the market.

Come meet us at Booth 513!


Visit Website

BioSpherix stands at the forefront of advanced cell and tissue culture technology, dedicated to providing Cytocentric® environments designed for optimal cell care. Our flagship product, the Xvivo System, exemplifies this commitment. By harnessing our proprietary closed-system technology, the Xvivo System revolutionizes cell science and is expertly tailored to meet the demands of your GMP or R&D protocols.


This modular and cost-effective system features patented self-sterilizing technology, offering a superior alternative to traditional open systems that expose cell and tissue cultures to unpredictable and non-physiologic conditions. The Xvivo System enhances operational efficiency, adapts to your evolving needs, minimizes contamination risks, and ultimately cultivates healthier, more robust cells.
At BioSpherix, our philosophy is Cytocentric®: prioritizing the needs of cells above all else.

Come meet us at Booth 444!


Visit Website

BioThrust provides the world's first truly scalable bioreactor that is especially well-suited to sensitive stem cells. BioThrust’s bionic bioreactor utilizes a unique and proprietary membrane architecture to facilitate bubble-free gas exchange at much higher efficiency than conventional systems.

 Foam formation is completely avoided with space-time yield increased by up to 250%. Our design supports linear scaling up to at least 200 L, guaranteeing uniform process conditions while never requiring harmful sparging. Our vision is to make cell therapies available to everyone!

Come meet us at Booth 825!

Visit Website

Immune cell therapy is a promising modality for treating cancer and autoimmune disease. In advanced hematological cancers, unprecedented cure rates of over 60% are achieved by six approved products. However, these therapies currently reach only about 20,000 patients, with demand exceeding supply. Manufacturing costs, duration, and quality are the main barriers to extending the field to less severe stages of cancer and other diseases.


BlueWhale Bio has identified the activation and expansion step of cells as a key barrier in production. This activation step is crucial as it is the initial stage where cells are engineered to become disease-fighting drugs. The consistency and effectiveness of this step determine subsequent processes and quality.


BlueWhale is developing a novel platform of cell-derived nanoparticle (CDNP) activation products that leverage naturally occurring immune stimulation to optimally condition cell therapies. Cell therapies produced using BlueWhale's process are less costly, require less time, and are more effective in killing tumor cells.


Visit Website

Broken String Bioscience’s technology platform, INDUCE-seq™, supports the development of cell and gene therapies that are safer by design.  

INDUCE-seq™, is an NGS-based DNA break mapping platform that enables companies developing cell and gene therapies to measure and quantify the specificity of off-target genetic edits and evaluate the associated genetic outcomes.

The platform provides data-driven, actionable insights across the discovery, pre-clinical and clinical development stages to advance gene editing programs. 


Come meet us at Booth 724!


Visit Website

C3i Center is a fully licensed Cell & Gene Therapy CDMO offering a full gamut of services from Development, Phase I/II, up to commercial manufacturing. We have GMP-validated clean rooms, comprehensive analytical testing, clinical CRO services, and cold chain logistical services.  We are the only CDMO in Canada with a DEL License from Health Canada and an approval from EMA to commercially manufacture cell therapies for the Canadian and European markets. We translate groundbreaking research into tangible cell and gene therapies, empowering healthcare providers to combat disease and improve patient outcomes.  We have a 15-year track record with a 99% manufacturing success rate in over 300 clinical productions.  

Come meet us at Booth 545!


Visit Website

CARR Biosystems is dedicated to transforming bioprocessing workflows across multiple markets, including gene therapy, cell therapy, vaccines, biologics, cellular agriculture, nucleic acids and microbial fermentation. Our innovative centrifuge solutions are engineered to deliver unmatched scalability, precision, and efficiency, empowering our partners to accelerate the development and production of life-saving therapies.

Come meet us at Booth 123!


Visit Website

Carrigent is a technology developer focusing on the cell and gene therapy industry. We are developing technologies for viral vector production, concentrating on three major problems in the space: production costs, gene-of-interest size limitations, and in vivo targeting. In addition, we provide contract research and pre-clinical process development services for the optimization of viral vectors and vector production systems to provide vectors that are more efficient and effective.
We have made breakthroughs in both the viral backbones and their expression systems, and our newest technology is our non-viral, non-lnp, non-vlp targeted payload delivery system, capable of delivering large sized protein, DNA or RNA directly to the cell type of interest and will be launching in 2025.

Come meet us at Kiosk #2 at the Innovation Zone!


Visit Website

CaseBioscience is a premier cGMP manufacturer specializing in advanced media and biopreservation solutions to drive innovation in cell therapy and regenerative medicine. As an ISO 13485:2016-certified company, we provide custom media optimization, manufacturing services, and high-performance cryopreservation solutions for stem and primary cells, to support basic, translational, and clinical research, as well as commercial applications. Our latest advancements in DMSO-free formulations outperform traditional alternatives, offering a safer, animal-free approach. Manufactured in our ISO 13485:2016 facility, our solutions meet cGMP standards, ensuring seamless integration into cell culture and cell therapy workflows.

Come meet us at Booth 630!


Visit Website

To be updated

Come meet us at Booth 341!


Visit Website

CellBios is a leading healthcare and life sciences company focused on advancing innovative single-use technology in the field of cell & gene therapy, regenerative medicine, infusion, bioprocess and biopharmaceuticals. We take pride in being the first in World to develop 51+ different fill choices of Cryopreservation bags and we offer 30+ different EVA transfer bags including Conical shape bags for Cell and Gene therapy markets. Our product portfolio also includes a diverse selection of freeze-thaw bags, transfer bags, specialized bags for cord blood and bone marrow processing, and a complete range of single-use consumables for various applications. With a commitment to improving global healthcare, CellBios harnesses cutting-edge technology through research, collaboration, and a patient-first approach to develop transformative treatments.

Come meet us at Booth 245!


Visit Website

Cellbox Solutions develops innovative logistics solutions for the global BioMed industry. Its flagship product, a portable incubator with active CO2 and temperature control, ensures the safe transport of living cells and biological samples under optimal laboratory conditions.

Come meet us at Booth 338!


Visit Website

CellBri is a biotechnology company specializing in advanced manufacturing solutions for cell therapies. We focus on developing automated, closed, digital, and regulatory-compliant systems for cell processing and fill-and-finish operations. Partnering with CellBri enables academic institutions, biotechnology firms, and pharmaceutical companies in the cell therapy field to accelerate drug development, enhance manufacturing capabilities, reduce process failures, lower production costs, and meet global patient needs.

Come meet us at Booth 907!


Visit Website

Cellex is a CDMO based in Germany with a deep expertise in manufacturing autologous & allogenic cell therapy products. We support customers from preclinical development stages through clinical manufacturing to commercialization. Our company is a trusted partner for large biotech and top 10 pharma companies as well as innovative start-ups and academia worldwide.
In addition to >2500m² GMP-facility for manufacturing CGT products, Cellex maintains an apheresis center and owns a donor database. With a highly diverse donor pool, we can provide all different kinds of starting materials, fresh and cryopreserved. Cellex portfolio includes leukopaks, mobilized leukopaks, bone marrow samples and whole blood products customized to the needs of the study for R&D, clinical and commercial use. All collections take place under GMP-conditions and can be delivered worldwide.
EU QP services, consultancy and GMP audits of apheresis centers worldwide complete the Cellex‘ portfolio.
Our clients value our expertise, quality and flexibility.

Come meet us at Booth 626!


Visit Website

Cellipont Bioservices is a leading cell therapy Contract Development and Manufacturing Organization (CDMO) dedicated to advancing cell therapy development and manufacturing. With a state-of-the-art cGMP manufacturing facility in The Woodlands, Texas, Cellipont offers comprehensive services from process development to commercial manufacturing. Their expertise spans various cell types, including CAR-T, TCR-T, dendritic cells, fibroblasts, natural killer cells, mesenchymal stem cells, hematopoietic stem cells, iPSCs and tumor-infiltrating lymphocytes.

The company is committed to empowering clients to bring life-changing medicines to patients worldwide. Their team of industry-leading experts provides tailored solutions to meet unique project requirements, ensuring the successful translation of innovative ideas into impactful therapies. Cellipont’s capabilities include best-in-class development, analytical, and manufacturing services, making them a trusted partner in the biotech industry.
Cellipont Bioservices mission is to shape the future of biotechnology by expanding patient access to life-changing medicines through scientific excellence and innovation.

Come meet us at Booth 222!


Visit Website

Cellistic specializes in process development and manufacture of immune cell therapies based on human induced pluripotent stem cell (iPSC) technology using their Pulse™ and Echo™ Platform. Its focus and expertise in iPSC reprogramming, gene editing using its proprietary STAR-CRISPRTM technology and differentiation development, positions the company to be the partner of choice for innovative cell therapy developers to advance into clinic. Leveraging more than a decade of scientific and technical knowledge and experience, Cellistic possesses unique capabilities for the design and optimization of proprietary manufacturing platforms for iPSC- based cell therapies.


Visit Website

Cellular Technology is a leading solution provider for immune monitoring supporting both research, pre-clinical and clinical studies phase I, II, III, IV and commercial. We help you to get the best possible, most reliable results, by offering a wide range of products and services, including:
CONTRACT LABORATORY SERVICES: Our CLEP/CLIA-certified laboratory can provide logistics (USA as well as globally), cryopreservation of functional PBMC from whole blood (serves as central blood processing laboratory in North America), ELISPOT, ELISA, NAb, multiplex Cytokine Bead Arrays (CBA), Flow Cytometry (phenotyping, ICS, multimer readouts etc.), Killer assays, MAT and more. CTL is developing, validating and performing low and high-throughput format testing, tailored to our clients’ needs.
INSTRUMENTATION: Image analyzers (ImmunoSpotR), high-throughput Analysis/Counting: ELISPOT, FluoroSpot, NK Assays, Viral Plaque (PRNT, FRNT, FFA), Bactericidal, Microbial Colony Counting, Genotoxic (MLA, AMES), Yeast Viability analysis, Stem Cell Assays and more….
CONSUMABLES: Cryopreserved functional PBMC: Over 150 HLA-typed donors with established reactivity to TH1/Th2 analytes to HLA Class I & Class II-restricted antigens. B and T Cell ELISPOT Kits to multiple species, FluoroSpot Kits ranging from single to multiplexed 4-color analytes and serum-free media, cryopreservation standardization solutions for functional PBMC generation and more…

Come meet us at Booth 609!


Visit Website

As a reputable cell sourcing provider, Charles River offers both research-use and GMP-compliant human immune and stem cells, as well as blood-derived and bone marrow products for advanced therapies. Our comprehensive offerings support clients at every stage, from basic research and discovery to safety assessment, manufacturing, and commercialization. With a diverse portfolio, global reach, and trusted scientific and regulatory expertise, we provide a complete solution that expedites the path to market. This gives our clients a valuable advantage in advancing their cell and gene therapy initiatives.

Come meet us at Booth 624!

Visit Website

ChemoMetec is a worldwide leading manufacturer of cell counting and analysis equipment. We specialize in developing and producing high-precision instrumentation, delivering consistent data for thousands of customers across biotech, pharma and academic segments.


We are experiencing exponential growth, as we strive towards our goal to be the number one provider in Life Sciences.


Designed, manufactured and tested in Denmark, we build our instruments and consumables with quality materials and dedicated expert workmanship.

Come meet us at Booth 822!

Visit Website

Clean Cells is a GMP certified and FDA inspected CRO/CMO offering quality control Services for all the biopharmaceutical products all along their development -
 From pre-clinical to marketed products. We support our partners to ensure the viral safety, identity, purity, genetic stability and potency of biologics. In addition, we propose a one stop shop solution for manufacturing and associated QC for GMP cells and virus banks.
Come meet us at Booth 843!


Visit Website

Cell Manufacturing Technologies (CMaT) is an NSF-funded multi-institutional engineering research center (ERC) with world leading expertise in transforming the manufacturing of cell-based therapeutics into large-scale, low-cost, reproducible and high-quality engineered systems. CMaT is dedicated to developing new fundamental knowledge; transformative new tools and technologies; integrated next-generation cell-manufacturing platforms; a diverse, inclusive, and well-trained workforce; and best practices, standards, and global thought-leadership.
Come meet us at Booth 708!


Visit Website

Cryo Bio System, Life Sciences division of IMV technologies Group, is exclusively dedicated to cryopreservation and cryobiology applications in biotechnologies such as reproductive medicine, fertility preservation, cell and gene therapies, biobanking, and biodiversity.
The company strives to provide innovative solutions dedicated to enhance precious biological samples to the highest standard of safety. Our long-time cryopreservation expertise in biobanking is combined with cutting-edge products with our unique high-security products portfolio, from straws to cryovials, and controlled-rate freezers.

Come meet us at Booth 909!


Visit Website

CryoStasis has developed a next-gen biopreservation platform that preserves cells & organoids by inducing stasis (hibernation), without ever freezing them. Since ice never forms, toxic cryoprotectants are unnecessary. CryoStasis uniquely enables scalable fill/finish while maintaining cell viability, function, phenotypic identity, purity, and potency from bioreactor to bedside. Preserve hundreds of allogeneic doses at a time. Prep doses in-house and simplify shipping. Stop freezing your cells to death(TM).

Come meet us at Booth 1012!

Visit Website

Cryotherm based in Kirchen, Germany, specialists in the construction and manufacturing of vacuum super insulated vessels and transfer lines for cryogenic liquid gases, such as helium, nitrogen, oxygen, argon and hydrogen.
These gases are used in industry – for instance in the chemistry, biotechnology, foodstuffs, aeronautics and aerospace industries – as well as in medicine and research.
In addition, Cryotherm provides project planning, manufacturing and installation, as well as innovative and market-oriented solutions for our customers' individual processes.
Cryotherm is certified according ISO 9001:2008, also has received certification as a manufacturer of pressure vessels and medical devices according to the European guidelines Pressure Equipment (PED), Transportable Pressure Equipment Directive (TPED), Medical Devices (MDD).

Come meet us at Booth 927!

Visit Website

CSafe offers the most comprehensive suite of thermal shipping solutions for pharmaceutical cold chain shipping needs around the world. With a “patient-first” focus, deep industry expertise and commitment to innovation, CSafe delivers industry-leading products in both the active and passive segments.

CSafe is the only provider with an end-to-end portfolio including active and passive bulk air cargo, parcel, cell and gene and specialty last-mile use cases and the ability to meet the complete range of pharma cold-chain shipping requirements with industry-leading quality and reliability.

Offering nearly any size, duration and temperature – CSafe is at the heart of your cold chain. csafeglobal.com

Come meet us at Booth 709!

Visit Website

CuraScript SD provides integrated delivery solutions for the safe & efficient distribution of specialty pharmaceuticals & associated medical supplies. We’ve been caring for those who care for more than a quarter of a century by supplying biologics, branded drugs, generics, vaccines, infused medications and ancillary supportive care products to a wide range of medical providers.

Come meet us at Booth 345!

Visit Website

Custom Biogenic Systems (CBS) has been a leading provider of cryogenic storage solutions for over 30 years. The company is known for its innovation in cryogenic storage and respected for its expertise in the life sciences. CBS specializes in the development and manufacturing of advanced cryogenic equipment, including unique Isothermal freezers with dry liquid nitrogen technology, which provides a safe and efficient method of cryogenic storage.

Come meet us at Booth 339!

Visit Website

CytoNiche is advancing the cell and gene therapy (CGT) industry through scalable 3D FloTrix technology, providing comprehensive solutions for CGT manufacturing. Our offerings include GMP-grade dissolvable microcarriers, serum-free media for mesenchymal stromal/stem cells, and a complete set of GMP-compliant equipment and consumables to support end-to-end cell expansion, harvesting, processing, and filling. Our vision and mission are to ignite a new era in industrial cell development, thereby empowering CGT advancements with intelligent 3D cellular mass manufacturing technology to benefit more patients.

Come meet us at Booth 522!

Visit Website

Cytotheryx is a platform technology company focused on developing a consistent, high-quality source of primary human hepatocytes, the functional cells of the liver, and the utilization of those cells in the research and therapeutic markets. Our proprietary technology was originally developed at, and is licensed from, the Mayo Clinic in Rochester, MN.

The availability of a high-quality source of primary human hepatocytes will open the door to developing curative treatments for liver disease, meeting several critical unmet needs.
Come meet us at Kiosk #3 at the Innovation Zone!


Visit Website

Daicel is a diversified technology company with unique capabilities that are being applied to a wide variety of applications, including Medical-grade plastics, Life-saving air bags, Engineered plastics, and the products of our Life Science SBU. Daicel’s Life Sciences SBU provides products for the increasingly complex needs of the Pharmaceutical and related businesses. Included in these capabilities are the following: Daicel’s world-leading Chiral Chromatography products and services, which are routinely used in the development and manufacture of pharmaceutical ingredients. The innovative Actranza® Jet Injection device, used to deliver RNA and DNA vaccines intracellularly without the use of needles, LNPs or other carriers. Pharmaceutical Standards for identification and quantification of drug materials. The most recent entry in our Life Sciences portfolio is an Exosome Isolation System which is designed to process up to 5 liters of feed into 20 ml in less than 2 hours. This proprietary system utilizes both chromatography and tangential flow filtration in a fully automated robust process, allowing for easy and efficient isolation of exosomes, with yield and purity rivalling that of any other method.

Come meet us at Booth 703!

Visit Website

Dark Horse Consulting Group is a specialist consulting firm that operates exclusively in the cell and gene therapy space. With our roots in CMC, today cover all areas of CGT product development, including manufacturing, process development, preclinical development, analytics, quality, regulatory affairs, project/program management, device development, facility design, and financing/investor relations (e.g. diligence processes).
All of our consultants have deep cell and gene therapy industry experience, spanning diverse functions and including experience from adjacent sectors, including traditional biologics, small molecules, medical devices and management consulting. As a result, we understand the unique challenges faced by CGT developers and are able to apply best practices from both within the CGT industry and beyond. Our team of CGT professionals bring deep technical expertise to help you tackle the unique challenges of our exciting young field.

Come meet us at Booth 723!

Visit Website

Defined Bioscience Inc. is a biotechnology company dedicated to advancing stem cell research and cell-based therapies by providing innovative, high-performance media formulations and reagents. Founded by a team of academic and industry experts, Defined Bioscience specializes in chemically defined, animal-free solutions that support consistent and scalable stem cell culture, differentiation, and organoid development.
Our product portfolio includes the HiDef™ series of culture media, Ready-CEPT™, and thermostable growth factors, all designed to enhance the reproducibility and efficiency of stem cell-based assays, biopharmaceutical production, and regenerative medicine applications. By eliminating variability in cell culture conditions, we empower researchers and biopharmaceutical companies to accelerate discovery and translational development.
Defined Bioscience operates as both a product supplier and a research partner, collaborating with leading biotech and pharmaceutical companies to optimize stem cell culture systems for drug development and cell therapy manufacturing. With a commitment to scientific excellence, rigorous quality control, and innovative solutions, we aim to enable the next generation of cell-based therapies.

Come meet us at Kiosk #4 at the Innovation Zone!


Visit Website

A global industry leader and innovator for over a century, Dickson is a trusted provider of high quality, reliable environmental monitoring technology designed to meet the most stringent regulatory requirements across industries from healthcare to pharmaceutical, life sciences, research and more. Dickson solutions empower organizations to effectively maintain compliance, safeguard often priceless assets, and seamlessly manage critical environments with confidence. One of the first to market with cloud-based solutions, Dickson monitors over 100,000 individual points and proudly serves more than 50,000 valued customers around the world. To learn more about our products and services, visit www.dicksondata.com.


Come meet us at Booth 440!


Visit Website

Digi-Trax is committed to transforming healthcare organizations across the world by applying barcoding and RFID strategies that increase patient safety, reduce medical errors, and improve workflows. Now and in the future, we will be with you every step of the way to implement and support the right strategy for your facility. We're your facility's single source solution for all your FDA compliant labeling needs.


Come meet us at Booth 710!


Visit Website

Discovery Life Sciences specializes in donor management and custom prospective collections of human-derived hematological tissues, serving across the cell and gene therapy (CGT) development continuum. Our AllCells® GMP and RUO products and services support global life science researchers and bio-manufacturing organizations in developing complex therapies and overcoming supply chain bottlenecks.


Come meet us at Booth 426!


Visit Website

ECL2 is the U.S. provider of Ideagen Quality Management (IQM) formerly Q-Pulse, a Quality Management System software implemented in over 80 countries worldwide. ECL2 currently supports numerous labs and has been featured in the newest edition of a book written by a widely respected expert on cellular therapy. 

Paired with our expertise within the life sciences area and specific to cellular therapy and blood banking, we are in the best position to advise our clientele on best practices relating to the automation of their programs. All our QMS consultants have been Quality professionals themselves and have been responsible for their own quality systems. 

We make the process a seamless one, because we’ve been through it.  ECL2 provides a complete solution starting from the initial sale, to delivering training and configuration while also supporting you in your ongoing needs. Our consultants also provide consulting services to those that require additional guidance in developing their Quality Management Systems.

IQM comes with all the modules integrated for a comprehensive solution. Allowing you to stay on top of training requirements with visual aids such as matrix views, equipment maintenance based upon a fixed period or on usage, it provides a complete document control solution linked to training plans, manages workflows for corrective and preventative actions, complaints, and anything else requiring a workflow. IQM provides a workload dashboard, so you know what is required of you, your team or entire organization. IQM also includes audit management, reporting and trending. Please stop by and see us!

Come meet us at Booth 220!


Visit Website

ElevateBio is a technology-driven company built to power transformative genetic medicines today and for many decades to come. The Company commercializes its enabling technologies, manufacturing capabilities, and industry-leading expertise through partnerships to accelerate development across a breadth of therapeutic approaches and modalities. The ElevateBio ecosystem combines multiple R&D technology platforms – including Life Edit, a next-generation, full-spectrum gene editing platform; comprehensive cell engineering technologies; and an expanded viral and non-viral therapeutic delivery platform – with BaseCamp®, its end-to-end genetic medicine cGMP manufacturing and process development business, to accelerate the discovery and development of advanced therapeutics.
ElevateBio aims to be the dominant engine inside the world’s greatest scientific advancements harnessing human cells and genes to alter disease.

Come meet us at Booth 524!



Visit Website

Entegris, Inc. (NASDAQ: ENTG) is a world-class supplier of advanced materials and ­­process solutions for the semiconductor, life sciences, and other high-tech industries. For over 50 years, we have been committed to solving our customers’ most demanding process challenges through a broad solutions portfolio, collaborative and innovative product development, and a focus on science and applications knowledge.

Entegris has ~8,000 employees throughout its throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service, and/or research facilities throughout United States, Canada, China, Germany, Israel, Japan, Malaysia, Singapore, South Korea, Taiwan and the United Kingdom. Our highly skilled team members, facilities and resources are right where you need them in order to help you solve your most advanced technology challenges.

Come meet us at Booth 940!



Visit Website

faCellitate is at the forefront of developing innovative biomimetic materials, essential for advancing applications in 3D cell culture, industrial biotechnology, regenerative medicine, and cell therapies. Leveraging a proprietary platform technology, faCellitate creates scalable, chemically defined surface coatings designed to meet the rigorous demands of modern life science research and industrial production.


The company's product portfolio features BIOFLOAT™, a top-performing solution for 3D spheroid production, and BIOINSTRUCT, a synthetic matrix tailored for the cultivation of induced pluripotent stem cells (iPSCs). These products are distinguished by their mechanical durability, ease of use, and capacity to support scalable production, enabling researchers and organizations to achieve reproducibility and high-performance results in their workflows.


faCellitate’s surfaces are engineered with a focus on precise cellular interactions, providing a defined and controlled environment that mimics natural cellular niches. This approach enhances cell viability, functionality, and differentiation, offering significant advantages for high-throughput screening, tissue engineering, and therapeutic development.


By integrating material science with cellular biology, faCellitate empowers users to overcome challenges associated with conventional culture methods, including variability and scalability. Headquartered in a leading biotechnology hub, the company is committed to advancing the frontiers of life sciences through continuous innovation and collaboration with research and industry partners.
With a clear focus on improving scientific outcomes and enabling new discoveries, faCellitate stands as a trusted partner in the rapidly evolving fields of biotechnology and regenerative medicine.

Come meet us at Kiosk #5 at the Innovation Zone!



Visit Website

FACT is a non-profit corporation founded for the purpose of voluntary inspection and accreditation in the field of cellular therapy, cord blood banking, and regenerative medicine. The objective of FACT is to improve the quality of cellular therapy through peer-developed standards, education and accreditation for the benefits of patients. FACT is the standards setting and accreditation arm of International Society for Cellular Therapy (ISCT) and the American Society of Blood and Marrow Transplantation.

Come meet us at Booth 340a!



Visit Website

Fresenius Kabi is a global health care company that specializes in lifesaving medicines and
technologies. Fresenius Kabi is a leader in transfusion medicine and offers a comprehensive
portfolio of transfusion technologies for manual and automated blood collection, separation
and storage, as well as therapeutic apheresis and cell collection procedures.

Come meet us at Booth 944!



Visit Website

Gateway Analytical is dedicated to helping therapeutic developers accelerate patient access to life-saving medicines. As a specialized analytical testing laboratory, we offer a comprehensive suite of services designed to help therapeutic developers and CDMOs mitigate the risks associated with developing and commercializing cell and gene therapy drugs. 

Our offerings include R&D and validation solutions for drug formulation and container development, which include extractables and leachables studies and container closure integrity testing. Additionally, we assist biotechnology and pharmaceutical companies in controlling and characterizing visible and subvisible particulate matter through rinse studies, particulate matter identification, and source determination investigations. Gateway Analytical is an ISO-accredited cGMP laboratory located in Pittsburgh, Pennsylvania, USA.

Come meet us at Booth 701!



Visit Website

GeneFab is a contract research and manufacturing organization focused on cell and gene therapies. GeneFab was formed in 2023 with a vision to combine industry leading expertise in synthetic biology with advanced cGMP capabilities in order to accelerate the development and commercialization of genetic medicines. GeneFab capabilities spans early stage product design, technical development and cGMP compliant production including CAR-T/CAR-NK Cells, iPSCs, engineered cell banks, lentiviral vectors, gammaretroviral vectors, AAV, mRNA, LNP and pDNA. GeneFab’s technology platform includes bioinformatic-guided discovery of cell type promoters, directed evolution of small molecule-regulated gene switches, the engineering of highly sensitive kill switches for enhanced safety and control of cellular therapies, and innovator-centric manufacturing platforms to accelerate novel therapies to patients in need. Across two facilities in Alameda and South San Francisco and facility soon in Singapore, GeneFab employs approximately 100 employees, including experts in cell, gene, and nucleic acid therapy, CMC, analytical development, process development and synthetic biology.

Come meet us at Booth 824!


Visit Website

Genesis BPS is a global manufacturer and supplier of precision equipment to clinical laboratories, life science customers, blood collection and cellular therapy organizations. Our product portfolio represents quality and consistency in a world of ever-changing requirements for processing, collection and storage.
Visit our booth to learn more about our tools for science including Dry Thawing Devices, Waferless Sterile Tube Welder’s, Tube Sealers, Collection Devices, Therapeutic Phlebotomy products, specialty blood bags and a whole lot more.
To learn more, visit our website at www.genesisbps.com or call one of our representatives at 866-71-BLOOD. Genesis BPS...Technology is in our blood!

Come meet us at Booth 925!


Visit Website

GenScript Biotech Corporation is the world‘s leading technology and service provider of life science R&D and manufacturing. Built upon solid gene synthesis technology, GenScript offers comprehensive services supporting gene and cell therapy development. From Gene Synthesis, CRISPR sgRNA, Non-viral Payload (ssDNA, dsDNA), mRNA, Oligo, Peptide synthesis, to protein, antibody and virus production. GenScript also offers CDMO platforms supporting GCT with cGMP CRISPR sgRNA/NVPs, plasmids, and virus.
We are dedicated to providing reliable, high-quality, and innovative reagents and instruments with superior customer service to enable success across a wide variety of existing and emerging life science research and development areas. We will help you Make Research Easy.

Come meet us at Booth 827!


Visit Website

Getinge is a trusted partner to thousands of leading medical and biotechnology facilities worldwide. From the intensive care unit to the operating room, from sterile processing to surgical procedures, architectural planning, research and pharma production, everything we do has one express goal — supporting you and your work in seeking the best possible outcome for every patient. That is Getinge's passion for life.

Come meet us at Booth 919!


Visit Website

Green Elephant Biotech is revolutionizing the field of biopharmaceutical manufacturing by addressing one of its greatest challenges: the production bottleneck for adherent cells. Founded in 2021 by Joel Eichmann and Felix Wollenhaupt, the company leverages cutting-edge technology with a focus on sustainable and scalable solutions to increase the accessibility and affordability of life-saving therapies.


Their flagship product is a novel cell expansion system designed to enhance production capacity for adherent cells. By significantly improving efficiency, CellScrew® helps overcome the industry's constraints, enabling scalable, automatable, and more economical manufacturing of biopharmaceuticals. This advancement is pivotal for expanding patient access to critical treatments, from cell and gene therapies to vaccines.


An innovative design, coupled with the use of plant-based polymer polylactic acid (PLA), significantly reduces waste and lowers the carbon footprint of the biopharmaceutical industry. By prioritizing the planet alongside patient needs, the company exemplifies how biotechnology can align with global sustainability goals.


Green Elephant recently introduced three versions of 96-well plates made from polylactic acid (PLA), expanding their portfolio for a more sustainable industry.

Come meet us at Booth 645!


Visit Website

Grifols Bio Supplies is a trusted source for human-derived materials that are used in pharmaceutical and diagnostic manufacturing, as well as in life science research. These materials are collected from Grifols' own network of blood and plasma centers in the USA and Europe.

Come meet us at Booth 640!


Visit Website

Halo Labs knows aggregates and particles. Aura® can count and characterize subvisible particles and tell you if they are aggregated drug product, excipients, or external contaminants.

A simple, plate-based approach enables low-volume, high-throughput, fully automated particle imaging and analysis at any stage from developability assessment through quality control.

Come meet us at Booth 627!

Visit Website

Fraunhofer IPT and Harro Höfliger bridge the gap between laboratory development and commercial production of ATMP therapeutics.

The production of ATMPs (Advanced Therapy Medicinal Products) of the highest quality requires individual production facilities and specific services. The focus here is on careful handling of the cell material.

The Fraunhofer Institute for Production Technology IPT and Harro Höfliger combine science and marketable technology to develop efficient solutions – fully automated and optimally designed for the product.


Come meet us at Booth 742!


Visit Website

The ISCT Institute of Training & Development is the first global CGT organization to achieve ANSI accreditation for Workforce Development, demonstrating ISCT’s leadership in addressing critical skill gaps within the rapidly evolving CGT sector. Leveraging the expertise of over 4,000 ISCT members—including leading subject matter experts and key opinion leaders from academia, industry, and regulatory agencies—the Institute plays a pivotal role in developing the global CGT workforce of the future. With a diverse portfolio of more than 11 internationally accredited training programs, the Institute collaborates with world-renowned centers of excellence to deliver tailored educational solutions to ensure participants receive world-recognized training, enhancing their technical skills and elevating their credibility in an increasingly competitive industry.


Come meet us at Booth 708!


Visit Website

The Japanese Society for Regenerative Medicine (JSRM) is one of the largest global societies dedicated to regenerative medicine, with approximately 6,000 members from diverse disciplines. These members engage in areas such as basic and clinical medicine, tissue engineering, cell biology, bioethics, regulatory science, law, and medical economics. JSRM serves as a cross-sector platform, bringing together academia, industry, and government stakeholders to address emerging challenges in the dynamic field of regenerative medicine.


In addition to facilitating global collaboration, JSRM has established a National Consortium (NC) that allows for the broader application of specialized knowledge and technical expertise, which was once limited to specific research institutions. This initiative aims to resolve bottlenecks in research and development and to support the resolution of technical and administrative challenges in clinical trials, ultimately advancing the commercialization of regenerative medicine.
JSRM is committed to facilitating innovation through discussions on critical topics in regenerative medicine. 　
At ISCT 2025, we will present 4 topics:
1. JSRM-ISCT Joint International Conference on iPSCs
2. Guidance on the Clinical Application of Extracellular Vesicles
3. Recommendations for the Safe Implementation of Intravenous Administration of Mesenchymal Stromal Cells
4. Basic Points to Consider for Cell Storage under the Act on the Safety of Regenerative Medicine

Come meet us at Booth 229!

Visit Website

Kincell is a technology-forward contract development and manufacturing organization (CDMO) that streamlines analytical development, process development, CMC consulting and GMP cell therapy manufacturing. Our focus is on developing and manufacturing immune cell therapies, including autologous and allogeneic CAR-T, CAR-NK, and CAR-M programs. 

Come meet us at Booth 543!

Visit Website

Kuraray is a global specialty chemistry company. Based on our mission of "For the sake of the world and people, we will do what others cannot do," we aim to grow sustainably by incorporating new elements into our unique technology and providing value to our customers. In particular, in the cell therapy industry, we aim to provide a variety of cell culture solutions, including microcarriers.

Come meet us at Booth 422!

Visit Website

Polysciences is proud to introduce Kyfora Bio, our bioprocessing brand, supporting development of cell and gene therapy(CGT) breakthroughs from bench to clinic. Backed by 60+ years of specialty chemical development, manufacturing, and application expertise, Kyfora provides research grade through cGMP transfection reagents and excipients for viral vectors, mRNA vaccines, and other drug delivery applications. Our cost-effective and scalable cGMP processes empower advanced therapies to improve patients’ lives.

Come meet us at Booth 239!

Visit Website

Kytopen, headquartered in Cambridge, Massachusetts is a leading biotechnology company specializing in the development and commercialization of non-viral continuous flow cellular engineering platforms to accelerate the processes of discovery, development, and the manufacture of advanced engineered cell therapies In 2023, Kytopen unveiled the Flowfect Discover™ 96-well platform, an automated high-throughput system for the optimization of genome engineering, and disclosed strategic partnerships with industry-leading contract development and manufacturing organizations (CDMOs) and cell therapy-focused medical centers. By combining the Flowfect Discover™ platform with the large-scale manufacturing Flowfect Tx™ system in process development workflows, cell therapy developers overcome manufacturing challenges, fostering swifter and more cost-effective innovation.

Come meet us at Booth 347!

Visit Website

Since 1984, MAK-System is a market leader in the digitalization of the transfusion medicine and the precision medicine domain. We create and deliver innovative technologies that are used to ensure the efficiency, compliance, and safety of the global supply of blood, plasma, and cellular products. Our clients located in more than 30 countries are: - Biopharma companies in the CGT domain - Blood & Plasma Centers - Hospitals: Transfusion Services, Blood Banks, Tissue Banks & Cell Therapy Labs

Come meet us at Booth 707!


Visit Website

Marken, UPS Healthcare Precision Logistics (formerly Marken, MNX & Polar Speed), the clinical and advanced therapy subsidiary of UPS Healthcare, unites expertise across healthcare, NFO, and complex secure logistics to drive the success of our clients through innovation.
Operating in 220+ countries and territories, our team of 4,000 experts orchestrate over 6.6M shipments annually at all temperature ranges across our harmonized air, sea and ground network. With a ready-now packaging catalog and global depot matrix, Marken MNX overcomes the most complex and evolving industry challenges, mitigating risks to always make it happen.
Marken MNX offers a complete range of services that integrates drug supply, storage and distribution, advanced therapy, radio pharma logistics, patient-driven services, laboratory logistics, kitting solutions, and connected medical device management.
By prioritizing quality and putting patients first, Marken MNX ensures time and temperature-critical shipments reach those who need them most.
We are ready. Now.
Experience. Our Precision.

Come meet us at Booth 346!


Visit Website

Matrixome is a Japanese-based company behind original creator of the laminin E8 fragment substrate and the gold standard pioneered by Professor Sekiguchi out of Osaka University. Already employed in numerous clinical trials and studies globally and trusted by large therapeutic and pharmaceutical companies around the world, the iMatrix product line, approved by the PMDA, is one you trust in your clinical trials. Come visit our booth to learn more.

Come meet us at Booth 122!


Visit Website

Mill Creek Life Sciences was the first company to commercially sell human platelet lysate (hPL). Born in a cGMP cell therapy lab, our human platelet lysates have been used to grow cells for thousands of patients globally in more than 50 Phase I, II, and III clinical trials for more than a decade.

Our hPL products are derived from human platelets and offer unparalleled cell growth in cellular therapy. Mill Creek Life Sciences is committed to discovering and applying innovative approaches to cellular therapy and patient care.

Our leading products are PLTGold® and PLTMax®, with gamma irradiated versions available. Initially developed for use with MSCs, our human platelet lysates have evolved into a platform technology that has been used with successful results with many other cell types and applications, including 2D and suspension cultures, as well as organoids. 

Additional cell types grown with our products include T cells, NK cells, tumor cells, endothelial cells, iPSCs, and more. Mill Creek Life Sciences was founded with a singular purpose in mind: to bring new solutions to accelerate cellular therapies for patients.

For us it is about quality, innovation and customer service. We work closely with our customers, helping fulfil their needs and supporting them through analyzing and troubleshooting specific applications when needed.

Come meet us at Booth 800!


Visit Website

Your contamination is our business. We develop, manufacture, and distribute innovative, robust, and susceptible methods to ensure the quality control of your biopharmaceutical/ATMP products in compliance with regulatory guidelines, such as VCN, sterility, mycoplasma, AAV titration, lentivirus, or endotoxin. In addition, we employ kits for cycler validation or DNA/RNA removal agents. Minerva Biolabs Inc. is located in New Jersey.

Come meet us at Booth 623!


Visit Website

NanoFCM provides a versatile and powerful platform - Flow NanoAnalyzer for the multiparameter analysis of functional nanoparticles (7-500 nm) at single-particle level which has the capacity to measure the size, concentration, and biological properties of nanoparticles. To our knowledge, Flow NanoAnalyzer is the only flow cytometry instrument that covers the size range of exosomes (30-120 nm). Flow NanoAnalyzer is expected to become a powerful tool for life science, nanoscience and nanotechnology studies.
Flow NanoAnalyzer can be used for the characterization of extracellular vesicles(EVs), viruses, bacteria, and other natural biological nanoparticles as well as functional nanoparticles, which opens up a window to the nano-world for flow technology. By means of high-selectivity, high-resolution and high-throughput detection of the particle size, concentration, and biochemical properties of a single nanoparticles (7-1000 nm).

Come meet us at Booth 323!


Visit Website

NecstGen is a non-profit CDMO and center of excellence for Cell and Gene Therapy, located in a purpose-built GMP facility at the Leiden Bio Science Park, the largest bio-cluster in the Netherlands. NecstGen provides critical contract development, manufacturing and rental services to academic and industrial therapy developers to deliver next-generation therapeutics to patients.
NecstGen offers:
  • Full contract manufacturing services for Cell Therapy and Viral Vector development and manufacturing
  • Process design, scale-up, optimization and automation for Cell Therapy and Viral Vector
  • Assay development for in-process, release, and potency testing
  • Cleanroom rental including services for QA, QC, and QP.

Come meet us at Booth 744!


Visit Website

At Nissan Chemical America, we are pioneering advancements in drug discovery and regenerative medicine through cutting-edge technologies and a commitment to scientific excellence. Our focus includes developing innovative solutions for oligonucleotide-based therapies, regenerative medicine, and stem cell research, which are reshaping the future of healthcare.
In the field of oligonucleotides, we offer specialized materials and technologies to enhance the stability, delivery, and efficacy of these promising therapeutics. By addressing key challenges, we support the development of targeted treatments for genetic disorders, cancer, and other complex diseases.
In regenerative medicine and stem cell research, our biomaterials enable breakthroughs in tissue engineering, cell culture, and advanced therapeutics. We provide high-quality products designed to support the growth, differentiation, and preservation of stem cells, paving the way for innovative approaches in healing and tissue repair.
Our expertise and collaborative approach empower biotech and pharmaceutical innovators to accelerate their research and bring novel therapies to market. By combining advanced chemistry with biological insight, Nissan Chemical America is helping to unlock the potential of these transformative medical technologies.
Through innovation and partnership, we aim to improve patient outcomes and contribute to a healthier, more sustainable world. Learn more about how we can support your research and development efforts: www.nissanchem-usa.com

Come meet us at Booth 1036!


Visit Website

At NMDPSM, we believe each of us holds the key to curing blood cancers and disorders. As a global nonprofit leader in cell therapy, NMDP creates essential connections between researchers and supporters to inspire action and accelerate innovation to find life-saving cures. With the help of blood stem cell donors from the world’s most diverse registry and our extensive network of transplant partners, physicians and caregivers, we’re expanding access to treatment so that every patient can receive their life-saving cell therapy. NMDP. Find cures. Save lives.

Come meet us at Booth 1010!


Visit Website

OmniAb licenses cutting edge discovery research technology to the pharmaceutical and biotech industries and academic institutions to enable the discovery of next-generation therapeutics. Our technology platform creates and screens diverse antibody repertoires and is designed to quickly identify optimal antibodies and other target-binding proteins for our partners’ drug development efforts.
Our proprietary transgenic animals, including OmniRat ® , OmniChicken ® and OmniMouse ® have been genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic ® and OmniClic ® are fixed or common light-chain rats and chickens, respectively, designed to facilitate the discovery of bispecific antibodies. OmniTaur ™ provides cow-inspired antibodies with unique structural characteristics for challenging targets. Omni dAb ™ is an in vivo platform for the discovery of single-domain antibodies based upon a human VH scaffold that affinity matures in a chicken host environment to provide a functionally diverse immune repertoire unavailable from mammalian systems. Our proprietary technologies are joined with and leverage OmniDeep ™ , which is a suite of in silico , AI and machine learning tools for therapeutic discovery and optimization that are woven throughout our various technologies and capabilities. Additionally, an established core competency focused on ion channels and transporters further differentiates OmniAb’s technology and creates opportunities in many important and emerging target classes.
OmniAb technologies can be leveraged for the discovery of a variety of next-generation antibody-based therapeutic modalities, including bi- and multi-specific biologics, antibody-drug conjugates, CAR-T therapies, targeted radiotherapeutics and many others.

Come meet us at Booth 938!


Visit Website

Organoid Sciences stands at the forefront of medical innovation, revolutionizing the landscape of immuno-oncology and personalized medicine through the innovative use of organoids. Our vision extends beyond treating diseases; we aim to transform the lives of patients by providing advanced, animal-free solutions that address the high unmet needs in today's medical landscape. Through our diverse collection of clinically relevant patient-derived organoid models and our highly experienced team of researchers, Lambda Biologics aims to be your partner in making today’s innovations, tomorrow’s tradition.

Come meet us at Booth 247!


Visit Website

OriGen Biomedical® is a leading producer of cryopreservation and cell culture products. OriGen’s focus is to produce a range of products to support the treatment of cancer, genetic conditions, and other life-threatening diseases. Our products are designed with the patient and user in mind and we strive to maintain excellent customer service to ensure that patient care is the priority. Our products are FDA-cleared, MDSAP-certified, CE-marked, cGMP-manufactured, and ISO 13485:2016 certified.

Come meet us at Booth 515!


Visit Website

OspreyBio is positioned to be the first end-to-end gene and cell therapy research tools and services company. Our mission is to empower researchers and companies to design, build, and optimize next-generation therapies with unparalleled precision and efficiency.


At the core of OspreyBio’s offerings is our flagship Bird of Prey (BoP) platform—the first modular and standardized DNA design and construction system. By leveraging a robust library of pre-made DNA modules, the BoP platform enables faster and more cost-effective vector construction, either in-house or as a service. Unlike other vendors, we tackle even the most complex multigenic vectors. Our library includes therapeutically relevant ORFs, bioRNA, novel promoters (Transcription Units), IRES elements, reporters, and more—each designed for seamless assembly and compatibility to meet the growing demands of modern genetic engineering.


In addition to our modular DNA tools, OspreyBio provides comprehensive vector assembly and construction services, supporting a broad range of applications. These include basic research vectors (e.g., reporter and protein/RNA expression) as well as translational research vectors (e.g., disease models and therapeutic constructs).


OspreyBio is dedicated to advancing groundbreaking R&D, therapeutic pipelines, and DNA construction. We proudly support academic labs, small biotech companies, and CROs as they push the boundaries of what’s possible in gene and cell therapy.


For more information, visit https://ospreybio.com or follow us on LinkedIn.

Come meet us at Kiosk #6 at the Innovation Zone!


Visit Website

PackGene Biotech is a world-leading CRO and CDMO, excelling in AAV vectors, mRNA, plasmid DNA, and lentiviral vector solutions. Our comprehensive offerings span from vector design and construction to AAV, lentivirus, and mRNA services. With a focus on early-stage drug discovery, preclinical development, and cell and gene therapy trials, we deliver cost-effective, dependable, and scalable production solutions. Leveraging our groundbreaking π-alpha 293 AAV high-yield platform, we amplify AAV production by up to 10-fold, yielding up to 1e+17vg per batch to meet diverse commercial and clinical project needs. Moreover, our tailored mRNA and LNP products and services cater to every stage of drug and vaccine development, from research to GMP production, providing a seamless, end-to-end solution.

Come meet us at Booth 227!


Visit Website

Bringing over 100 years of engineering expertise to the biopharmaceutical industry, Parker offers filtration, fluid management, sensing technologies, and customized single-use solutions for standalone use or incorporation into automated systems. Parker designs breakthrough bioprocessing technologies to aid our life sciences industry partners in developing and manufacturing pharmaceutical products and also supporting patient care by supplying essential components used in medical equipment.

Come meet us at Booth 541!


Visit Website

PeptiGrowth Inc., a joint venture between Mitsubishi Corporation and PeptiDream Inc., is supporting the growth of regenerative medicine and cell therapy industry by offering a series of synthetic peptides that have equivalent functions to growth factors. Our peptides are chemically synthesized, completely animal component-free, and can achieve highly consistent quality, excellent scalability, and reasonable cost.
PeptiGrowth has launched 11 products as of Oct 2024 – HGF, TGFβ1 inhibitor, BDNF, Noggin, BMP 4 or 7 selective inhibitor, VEGF, Wnt3a, EGF, TPO, and FGF2. We also have a plan to launch PDGF-AA, FGF7, and Interleukin peptides in 2025.
Come meet us at Booth 632!

Visit Website

phasetwo® offers a full range of storage products that have been re-engineered with a user-centric focus, rather than legacy and outdated designs. Our next generation solutions serve the Life Science sectors including Biotech, Cell and Gene Therapy, Dermatology, Biobanking, In Vitro Fertilization and more. Our advanced cold storage products include Cryogenic Storage Stainless Steel Freezers, Cryogenic Aluminum Freezers, Cryogenic Freezers, Cryogenic Control Rate Freezers, Cryogenic Blast Freezers, and Dry Ice Equipment.
Come meet us at Booth 344!

Visit Website

PhoenixBio ― supplier of the PXB-Mouse® and PXB-cells®, provides comprehensive drug development study services including those tailored for gene therapy involving liver-specific genes. The humanized liver PXB-Mouse® features up to 95% mouse-to-human hepatocyte replacement, ensuring accurate and predictable translatability in pre-clinical development studies resulting in accelerated discovery pipelines.
Come meet us at Booth 233!

Visit Website

Located in Aachen in Germany, PL BioScience GmbH is a life science company specializing in the production and development of Human Platelet Lysate (HPL), offering a complete portfolio of HPL products tailored for various use cases; from standard laboratory research to GMP compliant cell therapies.

PL BioScience was founded in 2015 as an RWTH Aachen University spin-off. Since then, they have been exploring the broad potential of human platelets with a mission is to enhance advances in cellular research and therapy with one forward-looking Technology: ELAREM™. The high growth factor content of HPL combined with its animal-free origin not only supports optimal cell growth, but also enables it’s use in various applications.

From academic research, pre-clinical research, to cellular therapy, the high quality GMP compliant standards of ELAREM™ ensures seamless transitions of regenerative medicine breakthroughs – from the lab to patients in need.
Come meet us at Booth 911!

Visit Website

Pluristyx is a leading provider of induced pluripotent stem cells (iPSC) and cell therapy solutions. The company offers a comprehensive suite of products and services designed to accelerate the development and commercialization of cellular therapies.
Pluristyx provides both research-grade and clinical-grade iPSCs, along with a range of gene editing technologies, including the proprietary FailSafe® edit for enhanced control of cell products. The platform also includes the panCELLa technology, which offers unique and effective non-modified and genetically engineered iPSC-based solutions.
With a team of experts in stem cell biology, developmental genetics, and cell therapy, Pluristyx supports clients throughout the entire product development pathway. Offerings include iPSC generation, gene editing, cell differentiation, and analytical services.
Pluristyx is committed to innovation and has recently been granted a patent for their groundbreaking induced Allogeneic Cell Tolerance (iACT Stealth™) technology. They have also filed a Drug Master File with the U.S. FDA for PluriBank™ iPSC lines, streamlining the regulatory process for clients.
Come meet us at Booth 1038!

Visit Website

HumanKine® recombinant cytokines & growth factors are produced at Proteintech’s GMP facility near Chicago, meaning complete control over the quality, scalability, and lot-to-lot consistency of the products. Proteintech also has the largest portfolio of self-manufactured antibodies, covering 2/3 of the human proteome and has acquired ChromoTek, a leader in Nanobody-based reagents.
Come meet us at Booth 643!

Visit Website

QIAGEN pushes the boundaries of innovation to improve our understanding of DNA, RNA and proteins – the building blocks of life. We enable our customers to unlock valuable insights from any biological sample – be it blood, a throat swab or many other materials. Our products serve a wide range of applications, including cell and gene therapy. In this space, customers can find solutions for precise determination of plasmid quality, viral titer, vector copy number and robust contaminant testing. Our reputation is based on confidence in decisions, clarity of results and pride in the insights our customers achieve. More than 35 Nobel Prize winners among more than 500,000 customers worldwide are proof of that success. Together, we are making improvements in life possible. Discover more at http://www.qiagen.com.
Come meet us at Booth 539!

Visit Website

QPS is a global, full-service, GLP/GCP-compliant contract research organization (CRO) delivering the highest grade of discovery, bioanalysis, preclinical and clinical drug development services. Since 1995, QPS has grown from a small bioanalysis shop into a full-service CRO with 1,100+ employees in the US, Europe, and Asia. Today, QPS offers expanded pharmaceutical contract R&D services with special expertise in pharmacology, DMPK, toxicology, bioanalysis, translational medicine, cell therapy products (such as Leukopaks and PBMCs), clinical trials, and clinical research services. An award-winning leader focused on bioanalysis and clinical trials, QPS is known for proven quality standards, technical expertise, a flexible approach to research, client satisfaction, turnkey laboratories, Phase I clinical facilities, and multi-site clinical research services. Through continual enhancements in capacities and resources, QPS stands tall in its commitment to delivering superior quality, skilled performance, and trusted service to its valued customers. For more information, visit www.qps.com or email info@qps.com.

Come meet us at Booth 725!


Visit Website

ReelReactor™ is a cutting-edge continuous micro-batch reactor designed to revolutionize biologics manufacturing. Unlike traditional batch systems, which suffer from poor scalability, inconsistent quality, and high costs due to time-dependent reactions, ReelReactor enables precise, scalable, and cost-effective continuous production.
Engineered for cell and gene therapy and other biologics, ReelReactor features functionally closed, sterile single-use consumables and biologically inert wetted materials. Its unique design ensures constant, gentle mixing, preserving product integrity, and it seamlessly integrates into larger workflows, eliminating bottlenecks.
By bridging the gap between batch and continuous manufacturing, ReelReactor empowers biopharma companies to accelerate development, reduce manufacturing costs, and improve product consistency. Whether for feasibility studies, small-scale manufacturing, or full-scale production, ReelReactor provides an innovative, flexible platform to meet the evolving needs of modern bioprocessing.

Come meet us at Kiosk #7 at the Innovation Zone!

Visit Website

From discovery to delivery, RegMedNet delivers news, expert insights, cutting-edge research and industry updates in regenerative medicine and advanced therapies.

Come meet us at Booth 340!


Visit Website

REPROCELL's corporate vision is to promote human health by providing cutting-edge research products, services, and partnerships that advance the future of Regenerative Medicine.

At REPROCELL, we can manufacture custom GMP iPSC or MSCs Master Cell Banks (MCB) compliant with the regulatory standards and guidelines of the FDA, EMA, and PMDA. The custom and the off-the-shelf iPSC Seed Clones are made with our 4th Generation clinical mRNA reprogramming technology and are available for the Sponsor to evaluate for suitability before the MCB generation step or clinical gene editing.

For drug discovery, REPROCELL’s pre-clinical contract research organization is an experienced partner uniquely positioned to provide custom assay services using live human tissues or 3D tissue models.

Our Central Laboratory Services offer a range of operational capabilities to accelerate drug development programs and support global clinical trial needs. From routine peripheral blood mononuclear cell (PBMC) processing to more complex genomic, proteomic, and cellular analyses, we deliver consistent quality-controlled sample handling and processing services to meet the demanding needs of innovative clinical research.

We can help with all areas of regenerative medicine preclinical development as REPROCELL has expanded through a series of acquisitions over recent years creating a workflow including human tissue acquisition (BioServe®), RNA reprogramming (Stemgent®), 3D technologies (Alvetex®), and drug discovery (Biopta®) to the development of clinical stem.

Come meet us at Booth 726!

Visit Website

RoosterBio accelerates human mesenchymal stem/stromal cell (hMSC) and extracellular vesicle (EV) product and process development to fuel the rapid implementation of scalable advanced therapies.

Our high-quality hMSCs, bioprocess media, genetic engineering tools, and EV production solutions are paired with expert bioprocessing knowledge to progress therapeutic developers from concept to first-in-human testing and commercial manufacturing at reduced cost and increased productivity.

With optimized, scalable processes, Type 2 Master Files, and cGMP products, we have enabled therapeutic programs to traverse their path to clinical translation in under 1 year.

RoosterBio is driven by clients’ success and creating a world where safe and effective regenerative medicines are rapidly developed and widely available on a global scale.

Come meet us at Booth 531!


Visit Website

Saint-Gobain Life Sciences is an industry-leading provider of material science-based solutions for single-use fluid management, including TPE and silicone tubing, connection and flow control components, bioprocess and cell culture bags, filtration products, sensors, and over-molded technology, all available in customized assemblies that are produced in 20 manufacturing facilities located around the world.

Come meet us at Booth 420!


Visit Website

Sanguine Biosciences is a committed partner for disease-state and healthy biospecimens. With our direct-to-donor model we lower the barrier for individuals to participate in research and provide the samples that researchers need. We bridge the gap between donors and researchers through direct-to-donor engagement, in-home collection of fully annotated biospecimens, apheresis product offerings, and a suite of biorepository services.

Come meet us at Booth 326a!


Visit Website

Santec was established in 1979, is headquartered in Aichi, Japan, and has subsidiaries in the U.S. (New Jersey and California), Canada, the U.K. and China. Santec is listed on the Standard Market (6777) a section of the Tokyo Stock Exchange. The company employs over 300 staff members and serves a global customer base: including internationally recognized clinical and research centers, the world’s major telecommunications companies and transmission/sub system manufacturers. Santec’s product lines include a broad range of advanced optical components, tunable lasers, optical test/measurement and OCT systems for life science, telecommunication, sensing and industry applications.

Come meet us at Booth 120!


Visit Website

The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) looks to complement the current SDO processes for standards development by engaging regenerative medicine stakeholders to ensure that new or revised standards pro-vide the greatest benefits to the field. To accomplish this and to keep up with the fast-paced growth of regenerative medicine and advance standards, SCB engages, coordinates, and educates the regenerative medicine community.

Come meet us at Booth 708!


Visit Website

Scinus Cell Expansion specializes in technologies and process development to advance cell therapy and regenerative medicine. Our main product, the SCINUS bioreactor NG, is a closed system designed for controlled cell cultivation, supporting both R&D and GMP processes. Paired with either the Adherent or Suspension bioreactor bag, it offers scalable cell expansion. The temperature-controlled hardware enclosure features an unique, volume-expandable, rocking platform, ensuring an optimal, low-shear culture environment. The system is versatile, accommodating both adherent cells (e.g. human mesenchymal stromal cells) or suspension cells (e.g. T-cells) with the same system configuration.

Visit our website for an illustrative animation: www.scinus.com.

Come meet us at Booth 924a!


Visit Website

SCTbio is a cell-based therapy and retroviruses vector CDMO spun out from SOTIO Group in 2021, led by a tight-knit team that has been through every stage of process and product development over the last decade, bringing Sotio Biotech’s autologous cell therapies into phase III. From its 2,000 sqm facility in Central Europe, SCTbio offers personal attention through long-term manufacturing partnerships, offering strategic development and regulatory guidance alongside full services covering GMP production, testing and logistics of advanced therapy medicinal products, including genetically modified and viral vectors.


SCTbio is supported by PPF Group.

Come meet us at Booth 926a!


Visit Website

Sekisui America Corporation serves as the regional headquarters for Sekisui Chemical, a global chemical manufacturer. We specialize in developing chemical solutions for the life science industry, with a particular focus on cell and gene therapy. Our product range includes cell culture consumables, such as state-of-the-art cell culture media and scaffolds.
Our chemically defined scaffold (CDS) is suitable for the AOF culture of pluripotent stem cells (iPSCs, ESCs, and MSCs, among others). This synthetic polymer can be stored at room temperature, pre-coated on a variety of surfaces, and adapted to automated culture equipment. It can establish a safe and stable cell culture process and reduce total cell culture costs.
We are seeking partners in the field of cell and gene therapy, including academic organizations, pharmaceutical companies, and automated bioreactor manufacturers, to collaborate on adapting our products for their pipeline.



Come meet us at Booth 700!


Visit Website

A leading contract service organization for over 40 years, SGS provides best-in-class services to support drug development from molecule to market, helping clients deliver high-quality, safe, and effective medicines to patients. With more than 20 GMP facilities worldwide, including five across North America, our global network of scientific experts accelerates large and small molecule drug development through a consultative and collaborative approach to assay development; comprehensive quality control testing for raw materials, APIs, and finished products; and bioanalytical testing to support phase 1 - 3 clinical trials.

Come meet us at Booth 332!


Visit Website

Founded in 2012, Slingshot Biosciences is a rapidly growing life sciences company on a mission to make cell mimics the gold standard for cell-based applications. With pioneering platform technology, Slingshot develops scalable, non-biological cell mimics that enhance diagnostics and therapeutics. By leveraging advancements in distributed manufacturing, engineering, and polymer chemistry, Slingshot Biosciences delivers off-the-shelf, cell-like reagents that are stable, cost-effective, and highly versatile across multiple indications.

Slingshot's flagship products include TruCytes™ biomarker mimics, SpectraComp® and HyParComp™ for next-generation flow cytometry compensation, FlowCytes™ for instrument standardization, and ViaComp®—the first-of-its-kind viability control. These innovations set new standards in flow cytometry and bioanalysis.

Headquartered in Emeryville, California, Slingshot Biosciences continues to drive breakthroughs in the life sciences, helping researchers and clinicians achieve consistency and reliability in their cell-based applications.

Come meet us at Booth 642!


Visit Website

SNBTS provide end to end solutions for Advanced Therapies, we offer a full range of consultancy, development, translation, CMC (chemistry, manufacture and control) and GMP-manufacturing services that can be tailored to your requirements.
We have over 20 years’ experience delivering autologous and allogeneic products for in vivo studies and First in Human, Phase 1 and Phase 2 trials. 
As a NHS establishment we are uniquely positioned to support academic and other early-stage developers in the translation of their ‘proof of concept’ stage products into GMP-compatible processes, and to manufacture these products for early-stage clinical trials. 
We have proven expertise working with somatic cells, pluripotent stem cells and their derivatives, and genetically modified cell therapies. 
Alongside our GMP capability we have extensive in-house Quality Control capacity specifically developed for Advanced Therapy Medicinal Products (ATMPs), including endotoxin and sterility, cell identity and function, and stability studies. 

Come meet us at Booth 638!


Visit Website

The Stem Cell Network (SCN) is a Canadian not-for-profit that supports stem cell and regenerative medicine research; training the next generation of highly qualified personnel; and knowledge mobilization and transfer of stem cell and regenerative medicine research. From the lab to the clinic, SCN’s goal is to power life-saving therapies and technologies through regenerative medicine research for the benefit of all.
Created in 2001, with support from the Government of Canada, the Network has grown from a few dozen labs to more than 270 world-class research groups, supporting over 250 research projects and 30 clinical trials. Since its inception, over 25 biotech companies have been catalyzed or enhanced and more than 7,000 highly qualified personnel have been trained. In 2023, the Government of Canada announced additional funding for SCN through the Strategic Science Fund that will support SCN activities and research through to the end of the decade.


Visit Website

STEMSOFT Software offers a fully electronic solution designed to document all phases of patient care and product manufacturing. Our software solutions allow you to save time, comply with quality and accreditation requirements, and easily access a complete dataset for analysis.

The latest ICCBBA specified ISBT-128 Cellular Therapy collection label templates are provided via our STEMSOFT LAB product, and our batch record software is configurable and workflow driven, allowing you to focus on producing your products.

Come meet us at Booth 601!


Visit Website

Symcel, the global leader in biocalorimetry, has a bold vision to redefine sterility testing for cell and gene therapies. By repurposing a microcalorimeter to measure microbial activity in real time, the Symcel calScreener+™ can detect phenotypic contamination earlier than any other system available. With significantly higher sensitivity than traditional sterility tests, sterility testing timelines can be reduced to under three days, a 70% decrease on the current gold standard.
For you as a cell and gene therapy producer, this breakthrough is a potential game-changer. It allows you to mitigate contamination risks, eliminates the issue of product matrices, simplifies manufacturing processes, and slashes your time-to-market.
With our global headquarters at the Karolinska Institute in Stockholm, we are a passionate, multidisciplinary team of 20 nationalities and with 15 PhDs.
Join us in transforming sterility testing.

Come meet us at Booth 841!


Visit Website

Almost 50 years of experience have made Technoflex the innovative firm, European leader in design and manufacture of flexible bags, associated connectors for the pharmaceutical industry. Our cutting-edge technology and internal R&D resources enable us to provide all-inclusive solutions, pioneering, reliable and easy-to-use. By intervening well upstream of its customers' requirements and by anticipating the technical, environmental and regulatory changes, Technoflex optimize the design of the future generations of flexible bags and associated connectors. Our proficiency of the manufacturing process in clean room ISO7 (Class 10000) allows us to provide innovative containers with a low AQL. The different ranges of bags, Inerta®, Biocell®, Cryocell®, SafeCell®, Dual-Mix®, ReadyMix®, developed by Technoflex are designed for various application such as: Cell therapies, Biotherapies, IV therapies, Compounding, Animal Health. All our bags are compliant with the European and American pharmacopoeias (FDA: DMF #19057 and Canada DMF # 2007-070)

Come meet us at Booth 936!


Visit Website

Telos Biotechnology is revolutionizing cell therapy manufacturing with TELOVANCE™, a proprietary telomere-lengthening platform designed to enhance the expansion and efficacy of engineered cell therapies. Telos’ breakthrough technology addresses a critical limitation in CAR T-cell therapy—T-cell senescence and exhaustion, which contribute to poor long-term remission rates.
The Challenge:
CAR T-cell therapy has transformed cancer treatment, but nearly 50% of adult patients fail to achieve durable responses. One major contributor is immunosenescence, where T-cells progressively lose function due to telomere shortening, limiting their expansion potential and persistence.
The Solution:
TELOVANCE™ is a recombinant human telomerase holoenzyme that transiently extends telomeres during ex-vivo CAR T-cell manufacturing, increasing replicative lifespan and cytotoxicity without genetic modification. Our in-vitro and in-vivo data demonstrate that TELOVANCE-treated CAR T-cells outperform untreated counterparts in durability and anti-tumor activity. The telomerase enzyme is naturally degraded within 48 hours, ensuring safe and transient telomere elongation.
Telos is actively collaborating with leading biotech, pharma and CDMO companies to integrate TELOVANCE™ into next-generation cell therapies.
For partnership inquiries, visit TelosBio.com or email info@telosbio.com

Come meet us at Kiosk #8 at the Innovation Zone!


Visit Website

Tolemy Bio is transforming the cell and gene therapy (CGT) industry by creating precision-engineered, custom cell culture media formulations. Using cutting-edge AI and machine learning, Tolemy unlocks new possibilities in cell metabolism optimisation that go beyond the limits of current methods. Our innovative, data-driven media solutions empower CGT manufacturers to accelerate development timelines, improve product quality, and bring life-saving therapies to patients faster than ever before.

Come meet us at Kiosk #9 at the Innovation Zone!


Visit Website

Trince offers a novel intracellular delivery (transfection) technology for the life sciences/biotech field.

The LumiPore platform is based on the interaction between pulsed laser light and photothermal nanomaterial. When irradiating the proprietary nanoparticles with laser light, highly localized light-induced thermal and mechanical forces are generated. When the nanoparticles are in close contact with the cell membrane, these light-induced forces can form transient pores in the membrane through which external effector molecules can enter the cell.

This ‘photoporation’ technology was developed as a next-generation intracellular delivery platform for efficient, flexible gentle, and safe delivery of a wide variety of effector molecules in a broad range of primary and hard-to-transfect cells, maintaining high therapeutic quality.

The technology can deliver a large variety of payloads in many different hard-to-transfect cell types, including suspension and adherent cells (directly in a standard lab recipient) and even living tissue slices.

Come meet us at Booth 845!


Visit Website

uBriGene Biosciences is your bridge from ATMPs concept to commercialization. Our CDMO+ services include cell therapy products (CAR-T, TCR-T, NK Cells, iPSC, Dendritic cells, Macrophages), viral vectors (AAV, LVV, RVV, AdV, oncolytic viruses), plasmids, and RNA (mRNA, circRNA, acRNA).  

Our extensive experience in manufacturing, QC testing, and regulatory filing support of ATMPs, from early discovery to commercialization, will accelerate your therapeutic programs from bench to bedside. 

With six Centers of Excellence for manufacturing and testing in North America, and APAC and more than 20 GMP clean room suites, uBriGene supports global CGT, vaccine, and RNA product development.

Come meet us at Booth 705!


Visit Website

In contrast to traditional contract development and manufacturing organizations (CDMOs), Vector BioMed is a solution provider that will provide partners with the capabilities to take their lentiviral vector-based medicinal concepts into the clinic and accelerate their path to commercialization. Vector BioMed addresses the industry's current vector supply bottleneck by offering rapid turn-key solutions for vector design and optimization, pre-clinical manufacturing, GMP manufacturing, and other support services.

Come meet us at Booth 937!



Visit Website

VectorBuilder, a global leader in gene delivery technologies, offers comprehensive solutions from research to clinical applications. Its Vector Design Studio is a sophisticated custom vector creation and online ordering platform, supported by advanced production, R&D, GMP facilities, and CRO services.

Come meet us at Booth 334!


Visit Website

Versiti offers blood products and CRO services to advance your research in cellular and immune therapies. We ensure availability and production of the highest-quality, most well-characterized blood products for research, including leukopaks, buffy coats, custom blood product and tube collections, and non-transfusable products. We bring together the best of multiple specialty organizations offering central lab, complex diagnostics, and regulatory strategy services to support your research needs.

Come meet us at Booth 326!


Visit Website

To be updated.

Come meet us at Booth 241!


Visit Website

ViruSure is an Austrian company specialising in the virus and prion safety testing of biopharmaceutical products, such as ATMPs. Our in vitro and in vivo facilities are certified to GLP/GMP standards to ensure a high standard for all our testing. Reflecting the quality of our biosafety testing services, our reports have been submitted and accepted by regulatory authorities worldwide. We work together closely with all our customers to develop the best testing strategy for their product. Our service portfolio includes: - Cell and Virus Banking - Cell and Virus Characterization - PCR (for detection of over 160 viruses and other pathogens) - Rapid Mycoplasma Testing by qPCR - Tumorigenicity & Oncogenicity Studies - Biodistribution Studies for ATMPs - Genetic stability - NGS - Sanger Sequencing - Virus/prion clearance studies - GMP storage - TEM

Come meet us at Booth 718!


Visit Website

VitaCyte manufactures, supplies, and directly sells defined collagenase & neutral protease enzymes for cell isolation or recovery of cells after culture. VitaCyte offers three categories of purified-defined collagenase products: lower-cost natural PD Collagenases and higher-cost natural and recombinant collagenases. These GMP Grade products are consistently manufactured (i.e., minimal lot-to-lot variability) and are > 95% pure. The recombinant collagenase is animal-origin-free.
VitaCyte also offers four purified GMP Grade neutral protease products: AM Protease, BP Protease (Dispase equivalent enzyme), Clostripain, and Thermolysin. AM Protease is used primarily for human amniotic cell isolation, whereas the other enzymes are used in a broad range of applications. All these enzymes are animal-origin-free except clostripain.
VitaCyte’s rigorous characterization of collagenase enzymes led to the development of four different reversed-engineered, purified-defined collagenase-protease mixtures used to isolate specific cell populations. These purified defined products replaced the inconsistent traditional collagenase products that required lot testing before purchase.
 VitaCyte provides a “reverse-engineering” service by first analyzing the client’s collagenase and protease enzymes, then reviewing these results with the client and proposing the substitution of these enzymes with a mixture of VitaCyte’s purified-defined enzymes that becomes a second source of enzyme. The benefits of this approach are that the client knows the biochemical properties of the enzymes used in their manufacturing process, can share these results with regulatory authorities, and has access to a second source of enzymes.
Come meet us at Booth 930!


Visit Website

Vitalant is leveraging its 80-year history of serving the healthcare community to build a Biotherapies-focused line of services. We are a trusted and reliable partner to hospitals, clinical practices, and biopharma customers. Our physical footprint and our clinical services connections create a robust infrastructure bridge between therapeutic developers and clinical systems to allow us to provide blood and stem cell therapy support reaching patients and donors across the country. We work with you to provide services in a clinical facility or in our growing number of fixed sites across 28 states. Vitalant is committed to keeping pace with science, technology, and the practice of medicine as it evolves.

Our Focus: Putting patients first to achieve high-quality patient outcomes in the community of their choice.

How:
- Standardized customization of service and support across our geographic footprint
- Relationships with hospitals, clinicians, biopharma and industry organizations
- Experts with depth and breadth in quality CGT clinical practice, research, and production

Where: Vitalant has a number of current and planned fixed sites, hospitals, and clinical practices, in addition to our mobile nurses and technicians on the go.

Vitalant is committed to building access pathways to life-saving and life changing biotherapies now and in the future for patients in their local communities.
Come meet us at Booth 1040!

Visit Website

Wacker Biotech is the all-in-one CDMO partner of choice for messenger ribonucleic acid (mRNA) production across the full nucleic acid manufacturing chain, from plasmid DNA (pDNA) to mRNA to LNP formulation, for vaccines and advanced gene therapies. Offerings include diverse solutions ranging from pDNA supply using our PLASMITEC® platform, to process development, transfer of mRNA-based processes, and GMP manufacturing for clinical and commercial supply. Additionally, customers benefit from a broad spectrum of LNP formulations for their mRNA-based product.
In June 2024, we completed construction and opened a state-of-the-art mRNA competence center in Halle, Germany, which effectively quadruples our mRNA production capacity. This complements existing capabilities at our global GMP facilities in Amsterdam, Halle and San Diego. Also complementing these sites is a dedicated R&D center in Munich, Germany with scientific experts leading innovations in pDNA manufacturing, mRNA production, LNP formulation, and analytical development.
Wacker Biotech is a wholly owned subsidiary of 110-year-old Wacker Chemie AG and also specializes in producing recombinant proteins based on microbial systems and Live Biotherapeutic Products. We offer the flexibility of a mid-sized CDMO combined with the stability and reliability of a large international public company committed to ongoing capital investments. For more information, visit: wacker.com/biologics.
Come meet us at Booth 321!

Visit Website

WellSky is one of America’s largest and most innovative healthcare technology companies. We offer a range of proven software solutions, analytics, and services that are transforming healthcare and public health through real-time connectivity, greater visibility, and relentless innovation. Put simply, we help organizations optimize care and performance, achieve better outcomes, and lower costs across the entire care continuum. Our flexible and data-rich solution strengthens communication and coordination across your research, manufacturing, clinical, and regulatory partners. WellSky Biotherapies enhances the donor and patient experience, simplifies resource management, tracks clinical trials through post-transplant follow up, and shares individualized treatment outcomes with key stakeholders. WellSky is best positioned to meet the allogeneic and autologous supply chain management needs of bone and marrow transplant programs, cell processing labs, research and manufacturing organizations, independent biobanks and repositories, and cord blood and tissue banks.

Come meet us at Booth 802!

Visit Website

West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.

Headquartered in Exton, Pennsylvania, West in its fiscal year 2023 generated $2.95 billion in net sales. West is traded on the New York Stock Exchange (NYSE: WST) and is included on the Standard & Poor's 500 index. For more information, visit www.westpharma.com.
Come meet us at Booth 428!

Visit Website

As a recognized world leader in pluripotent stem cell banking, distribution, and cell characterization services for over 25 years, WiCell provides the biotechnology industry, pharmaceutical industry, and related academic and research organizations with high-quality cell lines as well as accurate and reliable cell characterization and cytogenetic testing services.

The WiCell Stem Cell Bank provides a diverse range of human pluripotent stem cell lines, including embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), disease models, genetically modified variants, and cGMP grade cell lines. Our characterization services include non-GMP and cGMP karyotyping, Fluorescence in situ  Hybridization (FISH), and authentication via Short Tandem Repeat (STR) profiling. In addition, we offer non-GMP Single Nucleotide Polymorphism (SNP) microarray and mycoplasma testing.

Long-term liquid nitrogen storage is available through our WiCellSAFE program and tailored services like quality control testing and contract cell banking, designed to help laboratories maximize their resources efficiently, are also available through WiCell. 

Come meet us at Booth 527!


Visit Website

Xcell Therapeutics Inc. is a leading company in the field of medium development that launched the world`s first GMP-grade next-generation chemically defined medium for human MSCs, and aims to grow into a global medium development company that meets the demands of the advanced regenerative medicine and cell-gene therapy (CGT) markets.

Come meet us at Booth 327!

Visit Website

Founded in 2001 as a family-owned business, Xiogenix began by manufacturing steel rule dies for industries like printing and packaging. We soon expanded into biologic cutting dies and tissue processing equipment for the regenerative medicine field.

Today, we provide innovative solutions in cell and gene therapy, including fill & finish and cell homogenization. With over 200 pieces of equipment in use worldwide, we prioritize safety, efficiency, and compliance, while delivering exceptional service and single-use systems. Driven by innovation and customer satisfaction, we are dedicated to advancing regenerative medicine and beyond.

Come meet us at Booth 611!


Visit Website

X-Therma pioneers ground-breaking cold chain technology via a convergent bio-preservation platform, to advance the field of Regenerative Medicine and make available safe and on-demand engineered tissues, cell & gene therapies, vaccines, and beyond.

Come meet us at Booth 913!


Visit Website

  ISCT 2025 SUPPORTING ORGANIZATIONS 

 ISCT 2025 MEDIA PARTNERS